<?xml version="1.0" encoding="UTF-8"?>
<svg height="733.638" width="548.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="39.85" x="56.362,60.466,64.57" svgx:width="0.51,0.51,0.51" style="fill:rgb(0,0,0);font-family:MyriadPro-Regular;font-size:8.0px;stroke:none;">326</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M56.690 51.460 L538.690 51.460 "/>
  <g begin="text">
   <text y="93.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,74.925,78.563,82.2,83.843,88.628,89.933,91.575,96.3,100.283,101.85,103.493,108.345,111.825,113.13,114.773,118.778,122.76,126.75,128.393,132.435,133.74,135.383,140.168,144.248,147.653,149.22,150.863,154.598,157.958,159.263,160.905,164.138,168.12,169.688,171.33,176.01,180.285,181.59,182.97,188.925,192.915,194.558,198.038,201.938,203.243,204.57,207.593,210.998,217.14,218.52,224.835,230.64,231.945,233.587,237.862,241.882,245.287,249.307,250.95,256.785,261.06,262.365,263.745,269.7,273.69,277.71,281.79" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.45,0.49,0.49,0.22,0.64,0.17,0.22,0.63,0.53,0.21,0.22,0.65,0.46,0.17,0.22,0.54,0.53,0.53,0.22,0.54,0.17,0.22,0.64,0.54,0.45,0.21,0.22,0.5,0.45,0.17,0.22,0.45,0.53,0.21,0.22,0.62,0.57,0.17,0.22,0.82,0.53,0.22,0.46,0.5,0.17,0.22,0.47,0.45,0.82,0.22,0.82,0.82,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.78,0.57,0.17,0.22,0.82,0.53,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 12. Lee N, Hui DS, Zuo Z, Ngai KL, Lui GC, Wo SK, Tam WW, Chan MC, Wong </text>
   <text y="102.638" x="71.693,75.48,79.755,81.06,82.44,88.395,92.385,96.405,100.485,102.128,105.87,109.035,110.34,111.983,116.258,120.278,124.268,125.835,127.478,131.393,137.198,138.503,140.145,143.625,145.193,149.213,150.593,156.908,162.712,164.017,165.66,168.892,172.53,176.167,177.81,181.305,184.665,185.97,187.297,190.29,194.28,200.422,202.012,203.58,207.6,210.397,214.387,218.407,220.05,223.755,225.06,226.702,231.427,234.787,238.035,242.115,245.752,249.772,251.415,254.88,259.56,260.865,262.507,266.782,270.802,274.207,278.227,279.87,283.635,287.37" svgx:width="0.5,0.57,0.17,0.22,0.82,0.53,0.54,0.54,0.22,0.5,0.5,0.17,0.22,0.57,0.54,0.53,0.21,0.22,0.5,0.82,0.17,0.22,0.46,0.21,0.54,0.22,0.82,0.82,0.17,0.22,0.45,0.49,0.49,0.22,0.47,0.45,0.17,0.22,0.47,0.53,0.82,0.21,0.21,0.54,0.37,0.53,0.54,0.22,0.5,0.17,0.22,0.63,0.45,0.44,0.54,0.49,0.54,0.22,0.46,0.62,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.5,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">BC, Wong RY, Choi KW, Sin WW, Lee EL, Tomlinson B, Hayden FG, Chan PK </text>
   <text y="111.638" x="71.693,73.68,77.34,81.0,84.66,88.32,90.308,91.95,96.338,97.98,102.12,104.25,108.24,111.038,115.178,118.815,122.243,124.56,126.128,129.465,133.103,134.745,136.313,140.333,142.605,146.243,148.68,152.018,155.655,159.675,161.993,163.56,167.55,171.57,173.213,176.01,178.328,182.31,186.39,189.69,191.333,195.323,199.343,200.985,205.005,206.573,210.653,214.673,218.31,220.463,222.847,226.927,230.917,233.715,237.352,238.995,242.985,245.782,249.42,251.01,253.327,256.732,262.875,264.442,267.832,269.4,271.612,273.255,275.572,277.702,281.34,284.745,286.995" svgx:width="0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.58,0.22,0.55,0.29,0.53,0.37,0.55,0.49,0.45,0.31,0.21,0.45,0.49,0.22,0.21,0.54,0.31,0.49,0.29,0.45,0.49,0.54,0.31,0.21,0.53,0.54,0.22,0.37,0.31,0.53,0.54,0.44,0.22,0.53,0.54,0.22,0.54,0.21,0.54,0.54,0.49,0.29,0.3,0.54,0.53,0.37,0.49,0.22,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.31,0.29,0.49,0.45,0.31,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">(2013) A prospective intervention study on higher-dose oseltamivir treat-</text>
   <text y="120.638" x="71.693,77.835,81.473,85.493,87.81,89.453,91.02,95.04,96.683,100.088,104.168,108.15,109.74,112.058,114.855,116.498,120.518,124.508,127.305,131.445,133.013,135.33,138.735,140.325,141.893,144.855,148.493,152.573,154.215,159.63,161.198,163.515,167.535,169.178,170.745,174.765,178.395,182.378,186.015,190.035,193.058,196.463,198.105,201.51,203.153,206.558,210.578,214.658,216.3,220.088,221.73,223.298,227.318,229.17,232.808,236.235,238.553,240.12,244.11,248.13,250.845,252.15,253.793,258.068,259.658,261.225,265.245,266.888,268.583,272.603,274.455,278.093,281.52,283.838" svgx:width="0.82,0.49,0.54,0.31,0.22,0.21,0.54,0.22,0.45,0.54,0.53,0.21,0.31,0.37,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.21,0.4,0.49,0.54,0.22,0.72,0.21,0.31,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.45,0.22,0.45,0.54,0.54,0.22,0.5,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.37,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ment in adults hospitalized with influenza a and B infections. Clin Infect </text>
   <text y="129.638" x="71.693,76.545,78.113,80.91,82.553,86.213,89.873,91.178,94.838,98.498,102.158,105.818,109.568,113.228,116.888,120.548" svgx:width="0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Dis 57:1511–1519</text>
   <text y="138.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,76.478,80.468,84.105,85.695,87.338,91.38,95.168,96.473,98.115,101.903,105.308,108.105,110.423,111.99,116.01,117.653,123.488,126.263,129.413,130.718,132.36,138.255,142.245,146.265,148.538,152.618,156.608,162.75,166.388,168.825,172.125,173.768,178.155,182.543,183.848,185.49,188.82,190.41,193.815,197.835,201.855,205.492,207.93,211.23,212.872,217.26,221.985,223.627,225.615,229.275,232.935,236.595,240.255,242.242,243.885,248.115,252.105,258.247,262.387,265.792,268.056,269.624,272.421,276.411,280.431,282.074,286.064,288.029" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.64,0.53,0.49,0.21,0.22,0.54,0.5,0.17,0.22,0.5,0.45,0.37,0.31,0.21,0.54,0.22,0.78,0.45,0.47,0.17,0.22,0.78,0.53,0.54,0.31,0.54,0.53,0.82,0.49,0.29,0.44,0.22,0.58,0.58,0.17,0.22,0.46,0.21,0.45,0.54,0.54,0.49,0.29,0.44,0.22,0.58,0.63,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.57,0.53,0.82,0.55,0.45,0.29,0.21,0.37,0.53,0.54,0.22,0.53,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 13. Noel ZR, Bastin MLT, Montgomery AA, Flannery AH (2017) Comparison of </text>
   <text y="147.638" x="71.693,75.713,77.28,81.36,85.38,87.765,91.845,95.835,98.633,102.27,103.913,107.25,110.888,113.1,115.898,119.88,122.678,124.32,127.118,129.435,132.84,136.86,140.94,144.345,146.475,150.555,152.198,156.278,160.268,163.065,166.703,168.345,172.335,175.133,178.77,180.36,182.678,186.083,192.225,193.793,197.183,198.75,200.963,202.605,204.173,208.193,209.835,213.18,215.445,217.013,219.33,220.898,224.243,227.648,229.238,230.828,234.128,235.77,237.338,238.928,240.518,242.16,246.3,249.705,252.023,253.59,257.228,261.248,263.565,266.363,268.005,273.42,274.988,277.305,281.325" svgx:width="0.54,0.21,0.54,0.54,0.3,0.54,0.53,0.37,0.49,0.22,0.45,0.49,0.29,0.37,0.53,0.37,0.22,0.37,0.31,0.45,0.54,0.54,0.45,0.29,0.54,0.22,0.54,0.53,0.37,0.49,0.22,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.21,0.54,0.22,0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.21,0.21,0.21,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">high-dose versus standard dose oseltamivir in critically ill patients with </text>
   <text y="156.638" x="71.693,73.26,77.28,80.91,84.893,88.53,92.55,95.573,98.978,100.283,101.925,104.513,106.155,107.85,111.87,114.143,117.78,121.8,124.598,126.165,129.503,133.14,134.783,139.028,142.433,144.563,148.2,149.843,155.738,159.375,163.455,165.098,168.758,172.418,173.723,177.383,181.043,184.703,188.453,192.113,195.773" svgx:width="0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.17,0.22,0.34,0.22,0.21,0.54,0.31,0.49,0.54,0.37,0.21,0.45,0.49,0.22,0.57,0.45,0.29,0.49,0.22,0.78,0.49,0.54,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">influenza. J Intensive Care Med 32:574–577</text>
   <text y="165.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,75.21,79.2,83.183,85.5,89.52,91.163,94.658,98.063,100.86,103.178,104.82,109.148,111.945,113.513,116.918,118.56,120.255,124.275,126.129,129.766,133.193,135.51,137.078,141.068,145.05,147.848,149.49,154.343,155.91,158.708,162.345,165.75,168.548,172.185,173.828,178.103,179.693,181.26,185.28,186.848,190.193,193.598,195.188,196.83,200.655,204.293,207.09,210.728,214.133,216.263,219.608,223.628,225.27,230.055,231.698,233.685,237.345,241.005,244.665,248.325,250.313,251.955,255.48,259.433,263.07,266.497,268.815,270.457,274.447,276.412" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.46,0.53,0.53,0.31,0.54,0.22,0.47,0.45,0.37,0.31,0.22,0.58,0.37,0.21,0.45,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.53,0.37,0.22,0.65,0.21,0.37,0.49,0.45,0.37,0.49,0.22,0.57,0.21,0.21,0.54,0.21,0.45,0.45,0.21,0.22,0.5,0.49,0.37,0.49,0.45,0.29,0.45,0.54,0.22,0.64,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.54,0.49,0.45,0.31,0.22,0.53,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 14. South East Asia Infectious Disease Clinical Research N (2013) Effect of </text>
   <text y="174.638" x="71.693,75.773,79.763,83.745,87.885,89.475,93.113,94.755,98.835,102.825,105.623,109.26,110.903,114.893,117.69,121.328,122.918,125.235,128.64,134.783,136.35,139.74,141.308,143.52,145.163,149.153,153.173,154.815,158.16,159.75,161.318,165.338,166.905,170.25,173.655,175.245,176.888,180.293,184.313,188.393,190.035,193.425,194.993,197.123,201.113,202.703,206.693,210.713,212.28,215.625,219.03,220.62,222.263,226.253,230.235,232.508,235.853,239.843,245.985,249.623,252.42,254.063,255.63,259.65,261.293,264.638,268.658,270.225,271.815,275.895,278.026,281.664,285.684" svgx:width="0.54,0.53,0.53,0.55,0.21,0.49,0.22,0.54,0.53,0.37,0.49,0.22,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.53,0.54,0.22,0.45,0.21,0.21,0.54,0.21,0.45,0.45,0.21,0.22,0.45,0.54,0.54,0.22,0.45,0.21,0.29,0.53,0.21,0.53,0.54,0.21,0.45,0.45,0.21,0.22,0.53,0.53,0.31,0.45,0.53,0.82,0.49,0.37,0.22,0.21,0.54,0.22,0.45,0.54,0.21,0.21,0.54,0.29,0.49,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">double dose oseltamivir on clinical and virological outcomes in children </text>
   <text y="183.638" x="71.693,75.098,79.118,83.198,84.84,88.245,92.325,96.308,97.898,100.215,103.013,104.655,108.06,112.14,118.283,119.85,122.168,124.44,128.078,132.158,133.8,136.073,140.063,141.705,145.725,149.715,152.513,156.653,158.22,160.538,163.943,165.533,167.175,172.59,174.158,176.475,180.495,182.138,184.935,188.603,191.94,195.578,197.708,201.345,202.988,204.555,208.575,212.205,216.188,219.825,223.845,226.868,230.273,231.578,233.22,237.3,241.29,245.273,249.413,251.003,254.64,256.283,260.423,262.013,263.58,267.6,271.68" svgx:width="0.45,0.54,0.54,0.22,0.45,0.54,0.53,0.21,0.31,0.37,0.22,0.45,0.54,0.82,0.21,0.31,0.31,0.49,0.54,0.22,0.31,0.53,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.22,0.72,0.21,0.31,0.54,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.17,0.22,0.54,0.53,0.53,0.55,0.21,0.49,0.22,0.55,0.21,0.21,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">and adults admitted to hospital with severe influenza: double blind </text>
   <text y="192.638" x="71.693,73.905,77.31,81.33,85.41,89.4,95.543,97.11,99.908,103.545,107.625,109.268,112.613,116.603,120.623,122.94,125.07,129.06,130.65,132.24,135.878,139.958,141.6,143.918,146.182,147.75,151.155,152.662,153.967,155.61,159.397,165.232,167.82,169.462,173.122,176.782,180.442,181.747,183.712,187.372,191.032,194.692" svgx:width="0.29,0.45,0.54,0.54,0.53,0.82,0.21,0.37,0.49,0.54,0.22,0.45,0.53,0.54,0.31,0.29,0.53,0.21,0.21,0.49,0.54,0.22,0.31,0.29,0.21,0.45,0.21,0.17,0.22,0.5,0.78,0.34,0.22,0.49,0.49,0.49,0.17,0.26,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">randomised controlled trial. BMJ 346:f3039</text>
   <text y="201.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,74.925,78.563,84.705,88.11,89.678,91.995,94.125,97.763,99.405,102.112,103.417,105.06,108.292,112.275,115.575,117.892,119.535,123.81,127.305,128.61,130.252,134.076,138.066,142.049,143.639,145.229,148.866,151.124,153.359,157.183,160.821,164.841,168.831,170.421,174.058,177.463,181.446,183.088,185.796,187.101,188.743,193.64,195.207,198.845,201.642,204.665,207.92,211.872,217.287,220.085,223.452,226.857,228.499,232.887,234.192,235.834,239.877,243.282,247.302,249.514,251.157,255.942,257.247,258.889,263.119,267.109,269.547,272.884,276.874,278.464" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.45,0.49,0.82,0.45,0.21,0.31,0.29,0.49,0.22,0.46,0.17,0.22,0.45,0.53,0.44,0.31,0.22,0.57,0.47,0.17,0.22,0.5,0.53,0.53,0.21,0.21,0.49,0.31,0.3,0.5,0.49,0.54,0.53,0.21,0.49,0.45,0.53,0.22,0.46,0.17,0.22,0.64,0.21,0.49,0.37,0.4,0.42,0.53,0.72,0.37,0.42,0.45,0.22,0.58,0.17,0.22,0.54,0.45,0.54,0.29,0.22,0.64,0.17,0.22,0.57,0.53,0.29,0.45,0.53,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 15. Lemaitre F, Luyt CE, Roullet-Renoleau F, Nieszkowska A, Zahr N, Corvol </text>
   <text y="210.638" x="71.693,75.188,76.493,78.135,81.345,84.983,87.247,91.267,94.672,98.692,102.772,106.41,109.432,111.075,115.35,116.655,118.297,122.685,126.705,129.022,130.59,134.609,138.629,142.034,145.379,147.021,152.856,154.161,155.804,158.901,162.306,164.571,166.139,170.159,174.149,176.466,178.784,180.351,181.994,185.781,187.086,188.729,192.959,196.949,203.091,207.231,210.869,213.666,215.309,219.696,221.339,223.326,226.986,230.646,234.306,237.966,239.954,241.596,243.291,249.434,253.574,256.979,260.406,262.723,264.366,268.356,270.321" svgx:width="0.47,0.17,0.22,0.46,0.49,0.29,0.54,0.45,0.54,0.54,0.49,0.4,0.22,0.57,0.17,0.22,0.58,0.54,0.31,0.21,0.54,0.54,0.45,0.45,0.22,0.78,0.17,0.22,0.46,0.45,0.29,0.21,0.54,0.53,0.31,0.31,0.21,0.22,0.5,0.17,0.22,0.57,0.53,0.82,0.55,0.49,0.37,0.22,0.58,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.21,0.82,0.55,0.45,0.45,0.31,0.22,0.53,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">E, Fernandez C, Antignac M, Farinotti R, Combes A (2012) Impact of </text>
   <text y="219.638" x="71.693,75.33,78.645,80.963,83.175,86.58,89.925,93.915,96.18,100.32,104.31,106.44,110.078,113.483,115.073,116.715,122.858,126.495,132.638,136.778,138.99,142.395,146.415,150.053,151.695,155.625,158.933,162.18,166.26,169.898,173.918,177.323,179.64,181.208,185.198,189.218,190.86,194.265,198.285,202.365,204.008,207.353,211.343,215.363,217.68,219.248,223.268,227.25,231.24,235.223,238.02,239.663,243.0,246.638,250.658,254.61,257.948,261.585,265.605,269.595,273.578,276.375" svgx:width="0.49,0.43,0.31,0.29,0.45,0.45,0.53,0.29,0.55,0.53,0.29,0.49,0.45,0.21,0.22,0.82,0.49,0.82,0.55,0.29,0.45,0.54,0.49,0.22,0.53,0.43,0.44,0.54,0.49,0.54,0.45,0.31,0.21,0.53,0.54,0.22,0.45,0.54,0.54,0.22,0.45,0.53,0.54,0.31,0.21,0.54,0.53,0.53,0.53,0.37,0.22,0.45,0.49,0.54,0.53,0.45,0.49,0.54,0.53,0.53,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">extracorporeal membrane oxygenation and continuous venovenous </text>
   <text y="228.638" x="71.693,75.713,79.35,85.493,89.483,93.563,95.13,98.535,102.165,103.755,106.073,108.285,111.69,114.008,115.575,119.565,123.585,125.228,129.218,133.238,134.88,137.198,141.218,144.855,146.498,150.638,154.658,158.063,160.328,166.47,169.875,173.22,177.21,180.547,182.115,186.135,189.772,192.09,193.657,197.002,199.8,201.442,205.432,207.397,209.04,213.03,215.827,219.465,221.055,223.372,226.777,232.92,234.487,237.877,239.445,241.657,243.3,246.645,250.05,252.322,256.462,260.392,263.7,267.0,268.59,271.995,274.267,277.905,279.547,281.115,285.135" svgx:width="0.54,0.49,0.82,0.53,0.54,0.21,0.45,0.48,0.21,0.31,0.29,0.45,0.31,0.21,0.53,0.54,0.22,0.53,0.54,0.22,0.31,0.54,0.49,0.22,0.55,0.54,0.45,0.29,0.82,0.45,0.45,0.53,0.42,0.21,0.54,0.49,0.31,0.21,0.45,0.37,0.22,0.53,0.26,0.22,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.45,0.45,0.29,0.55,0.53,0.43,0.44,0.21,0.45,0.31,0.49,0.22,0.21,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in </text>
   <text y="237.638" x="71.693,75.038,77.303,78.87,81.188,82.755,86.1,89.505,91.095,92.685,95.985,97.628,99.195,100.785,102.375,104.018,108.158,111.563,113.88,115.448,119.085,123.105,125.423,128.22,129.863,135.278,136.845,139.163,143.183,144.825,148.965,152.37,156.39,160.47,164.108,170.25,171.818,175.163,176.805,178.793,183.518,187.178,191.963,195.623,197.61,199.253,200.82,204.84,208.47,212.453,216.09,220.11,223.133,226.538,227.843,229.17,232.628,236.648,240.285,242.498,244.14,248.993,251.205,255.188,259.268,260.91,266.805,270.795,274.815,276.383,278.7" svgx:width="0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.21,0.21,0.21,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22,0.55,0.45,0.54,0.54,0.49,0.82,0.21,0.45,0.22,0.26,0.63,0.49,0.64,0.49,0.26,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.17,0.22,0.47,0.54,0.49,0.29,0.22,0.65,0.29,0.53,0.54,0.22,0.78,0.53,0.54,0.21,0.31,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">critically ill patients with pandemic (H1N1) influenza. Ther Drug Monit </text>
   <text y="246.638" x="71.693,75.353,79.013,80.318,83.978,87.638,91.298,95.048,98.708,102.368" svgx:width="0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">34:171–175</text>
   <text y="255.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,74.925,78.563,82.2,83.843,88.628,89.933,91.575,95.85,99.87,103.275,107.295,108.938,112.703,116.603,117.908,119.288,125.243,129.233,133.253,137.333,138.975,143.25,147.15,148.455,149.835,155.79,159.78,163.8,167.88,169.522,173.482,176.632,177.937,179.58,183.855,187.875,191.865,193.432,195.075,198.989,204.794,206.099,207.741,210.359,214.311,217.611,221.631,223.949,225.591,230.271,236.106,237.411,239.054,242.414,245.819,251.961,253.604,256.334,257.639,259.281,263.556,267.576,270.981,275.001,276.644,282.479,286.754,288.059" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.45,0.49,0.49,0.22,0.64,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.5,0.17,0.22,0.82,0.53,0.54,0.54,0.22,0.57,0.5,0.17,0.22,0.82,0.53,0.54,0.54,0.22,0.5,0.47,0.17,0.22,0.57,0.54,0.53,0.21,0.22,0.5,0.82,0.17,0.22,0.34,0.53,0.44,0.54,0.31,0.22,0.62,0.78,0.17,0.22,0.45,0.45,0.82,0.22,0.5,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.78,0.57,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 16. Lee N, Chan PK, Wong CK, Wong KT, Choi KW, Joynt GM, Lam P, Chan MC, </text>
   <text y="264.638" x="71.693,77.648,81.638,85.658,89.738,91.38,95.168,99.443,100.748,102.39,105.622,109.605,111.172,112.815,117.495,121.77,123.075,124.717,128.197,129.765,133.785,135.165,141.48,147.285,148.59,149.97,155.925,159.915,163.935,168.015,169.657,173.399,176.564,177.869,179.511,182.871,186.276,192.419,193.799,199.949,203.114,204.419,205.686,209.039,212.676,216.659,220.679,224.759,226.401,230.721,234.996,236.301,237.944,241.176,244.814,248.796,252.816,256.896,258.224,261.711,264.419,265.724,267.366,270.884,274.874,276.516,281.241,284.406,285.711" svgx:width="0.82,0.53,0.54,0.54,0.22,0.5,0.57,0.17,0.22,0.45,0.53,0.21,0.22,0.62,0.57,0.17,0.22,0.46,0.21,0.54,0.22,0.82,0.82,0.17,0.22,0.82,0.53,0.54,0.54,0.22,0.5,0.5,0.17,0.22,0.45,0.45,0.82,0.22,0.82,0.5,0.17,0.22,0.5,0.49,0.53,0.54,0.54,0.22,0.58,0.57,0.17,0.22,0.45,0.49,0.53,0.54,0.54,0.22,0.47,0.46,0.17,0.22,0.46,0.53,0.22,0.63,0.5,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Wong BC, Lui GC, Sin WW, Wong RY, Lam WY, Yeung AC, Leung TF, So HY, </text>
   <text y="273.638" x="71.693,75.15,79.133,80.775,84.788,90.593,91.898,93.54,97.02,101.003,105.023,109.103,110.745,113.333,115.808,117.113,118.755,123.48,127.463,129.03,130.673,135.525,139.005,140.648,142.635,146.295,149.955,153.615,157.275,159.263,160.643,164.393,165.96,168.173,171.578,173.168,174.81,178.155,179.745,183.383,186.788,189.0,192.405,196.425,199.77,203.408,205.05,208.455,212.475,216.555,218.198,219.765,223.785,227.415,230.82,236.963,243.105,246.51,248.783,252.773,255.21,258.51,260.153,262.283,265.92,268.718,272.858,276.848,280.868,283.665,287.303" svgx:width="0.5,0.53,0.22,0.58,0.82,0.17,0.22,0.46,0.53,0.54,0.54,0.22,0.34,0.34,0.17,0.22,0.63,0.53,0.21,0.22,0.65,0.46,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.51,0.21,0.29,0.45,0.21,0.22,0.45,0.21,0.49,0.45,0.29,0.45,0.54,0.45,0.49,0.22,0.45,0.54,0.54,0.22,0.21,0.54,0.48,0.45,0.82,0.82,0.45,0.31,0.53,0.29,0.44,0.22,0.29,0.49,0.37,0.55,0.53,0.54,0.37,0.49,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Yu AW, Sung JJ, Hui DS (2011) Viral clearance and inflammatory response </text>
   <text y="282.638" x="71.693,75.833,79.238,81.555,83.828,87.465,89.73,93.75,96.547,98.182,99.75,103.77,105.405,108.81,112.89,116.872,118.462,120.78,123.577,125.212,129.232,133.222,136.02,140.16,141.727,144.045,147.45,149.04,150.607,153.57,157.207,161.287,162.922,164.775,168.765,170.977,172.612,176.752,180.157,184.177,188.257,191.895,198.037,199.605,202.95,204.585,208.245,211.905,215.565,219.225,220.86,222.427,226.447,230.077,234.06,237.697,241.717,244.74,248.145,249.78,254.167,256.155,260.88,264.54,269.325,272.985,274.972,276.607,279.997,281.565,283.777,287.76,290.557" svgx:width="0.55,0.45,0.31,0.31,0.49,0.29,0.54,0.37,0.22,0.21,0.54,0.22,0.45,0.54,0.53,0.21,0.31,0.37,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.21,0.4,0.49,0.54,0.22,0.26,0.53,0.29,0.22,0.55,0.45,0.54,0.54,0.49,0.82,0.21,0.45,0.22,0.49,0.49,0.49,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.58,0.26,0.63,0.49,0.64,0.49,0.26,0.22,0.45,0.21,0.29,0.53,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus </text>
   <text y="291.638" x="71.693,75.833,79.853,83.49,87.473,93.615,97.605,101.625,103.193,106.598,107.903,109.545,113.933,117.953,120.27,121.838,125.228,126.795,129.008,130.335,133.793,137.813,141.45,143.663,145.305,148.965,152.625,153.93,157.59,161.25,164.91,168.66,172.32,175.98" svgx:width="0.55,0.54,0.49,0.53,0.82,0.53,0.54,0.21,0.45,0.17,0.22,0.58,0.54,0.31,0.21,0.45,0.21,0.29,0.22,0.47,0.54,0.49,0.29,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">pneumonia. Antivir Ther 16:237–247</text>
   <text y="300.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,75.48,79.118,83.138,84.705,86.295,87.885,89.453,91.043,92.685,96.165,97.47,99.113,105.008,108.368,111.668,113.31,116.018,117.323,118.965,122.175,126.165,130.148,132.36,135.765,138.083,139.65,141.293,144.773,146.078,147.72,150.953,154.935,158.235,160.553,162.195,166.47,169.965,171.27,172.913,177.188,181.208,182.775,186.12,190.14,193.778,197.918,201.908,204.315,206.632,208.2,211.545,215.565,219.202,220.53,223.68,224.985,226.627,230.145,234.135,238.155,242.175,245.842,249.232,250.8,252.39,253.98,257.617,259.26,263.047,264.352" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.5,0.49,0.54,0.21,0.21,0.21,0.21,0.21,0.22,0.46,0.17,0.22,0.78,0.45,0.44,0.22,0.46,0.17,0.22,0.46,0.53,0.53,0.29,0.45,0.31,0.21,0.22,0.46,0.17,0.22,0.45,0.53,0.44,0.31,0.22,0.57,0.47,0.17,0.22,0.57,0.54,0.21,0.45,0.54,0.49,0.55,0.53,0.29,0.31,0.21,0.45,0.54,0.49,0.22,0.47,0.17,0.22,0.46,0.53,0.54,0.54,0.49,0.45,0.21,0.21,0.21,0.49,0.22,0.5,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 17. Behillil S, May F, Fourati S, Luyt CE, Chicheportiche T, Sonneville R, </text>
   <text y="309.638" x="71.693,74.715,78.12,82.14,86.22,87.825,91.23,95.22,99.203,100.77,103.005,106.365,109.77,115.913,120.053,121.62,125.61,127.928,130.2,133.838,135.105,138.27,139.575,141.218,145.042,149.032,153.015,156.232,157.875,162.502,163.807,165.45,170.13,174.112,177.75,180.014,181.581,185.601,187.244,190.604,191.909,193.551,199.446,202.806,206.106,209.511,213.494,216.711,218.354,220.828,222.133,223.776,229.671,233.076,237.058,239.496,242.796,244.438,247.933,249.238,250.881,254.09,257.727,259.992,262.122,265.76,267.402,271.79,273.095" svgx:width="0.47,0.45,0.54,0.54,0.21,0.45,0.53,0.53,0.21,0.3,0.45,0.45,0.82,0.55,0.21,0.53,0.31,0.31,0.49,0.22,0.5,0.17,0.22,0.5,0.53,0.53,0.43,0.22,0.65,0.17,0.22,0.62,0.53,0.49,0.29,0.21,0.54,0.22,0.45,0.17,0.22,0.78,0.45,0.44,0.45,0.53,0.43,0.22,0.34,0.17,0.22,0.78,0.45,0.53,0.29,0.44,0.22,0.47,0.17,0.22,0.46,0.49,0.29,0.29,0.49,0.22,0.58,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Tandjaoui-Lambiotte Y, Roux D, Guerin L, Mayaux J, Maury E, Ferre A, </text>
   <text y="318.638" x="71.693,76.41,80.048,84.038,86.183,90.263,93.9,96.113,97.755,100.343,103.05,104.355,105.735,109.358,113.348,114.915,117.18,118.748,122.738,125.055,126.698,131.378,132.683,134.325,137.82,141.84,145.83,149.813,151.778,153.158,156.63,157.935,159.578,162.968,166.373,170.393,172.035,176.115,179.753,181.965,183.345,189.3,192.938,195.39,197.355,198.998,202.478,203.783,205.425,211.32,214.958,218.213,222.203,226.223,228.54,231.338,235.328,236.97,241.725,246.112,247.417,249.06,253.14,256.777,258.42,262.027,264.157,268.147,270.945,273.262,274.905,279.69" svgx:width="0.62,0.49,0.53,0.29,0.54,0.49,0.29,0.22,0.34,0.46,0.17,0.22,0.51,0.53,0.21,0.29,0.21,0.53,0.31,0.22,0.62,0.17,0.22,0.47,0.54,0.53,0.53,0.26,0.22,0.51,0.17,0.22,0.45,0.45,0.54,0.22,0.54,0.49,0.29,0.22,0.82,0.49,0.29,0.26,0.22,0.46,0.17,0.22,0.78,0.49,0.42,0.53,0.54,0.31,0.37,0.53,0.22,0.65,0.58,0.17,0.22,0.54,0.49,0.22,0.5,0.29,0.53,0.37,0.31,0.22,0.64,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Georger JF, Voiriot G, Enouf V, van der Werf S, Mekontso DA, de Prost N </text>
   <text y="327.638" x="71.693,73.68,77.34,81.0,84.66,88.32,90.308,91.95,96.983,99.78,103.418,105.008,107.325,110.73,116.873,118.44,121.83,123.398,125.61,127.253,129.383,133.02,135.818,137.385,140.183,142.5,145.905,149.925,153.27,156.908,158.55,160.118,164.138,165.78,168.578,172.245,175.582,179.22,181.35,184.987,186.63,188.197,192.217,195.847,199.83,203.467,207.487,210.51,213.915,215.557,219.945,221.932,226.657,230.317,235.102,238.762,240.75,244.89,248.97,255.112,258.772,262.432,264.075,268.215,272.235,275.872,279.855" svgx:width="0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.67,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.29,0.49,0.37,0.21,0.37,0.31,0.45,0.54,0.45,0.49,0.22,0.21,0.54,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.58,0.26,0.63,0.49,0.64,0.49,0.26,0.55,0.54,0.82,0.49,0.49,0.22,0.55,0.54,0.49,0.53,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">(2019) Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneu-</text>
   <text y="336.638" x="71.693,77.835,81.825,85.845,87.413,90.818,92.46,95.865,99.885,103.965,105.608,109.013,112.358,116.34,118.613,122.25,123.893,126.023,129.66,132.458,136.598,138.165,140.378,143.783,146.055,150.045,152.482,155.782,157.425,161.505,163.072,165.87,168.187,170.317,173.955,176.752,179.55,181.192,183.99,187.29,191.31,195.39,197.52,201.51,207.652,211.29,212.595,214.237,217.642,219.285,222.524,224.654,228.291,232.311,235.656,239.676,241.319,247.461,251.444,253.034,255.351,256.919,260.264,263.901,267.921,270.194,273.831,276.044" svgx:width="0.82,0.53,0.54,0.21,0.45,0.22,0.45,0.54,0.54,0.22,0.45,0.45,0.53,0.31,0.49,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.54,0.21,0.37,0.31,0.29,0.49,0.37,0.37,0.22,0.37,0.44,0.54,0.54,0.29,0.53,0.82,0.49,0.17,0.22,0.45,0.22,0.46,0.29,0.49,0.54,0.45,0.54,0.22,0.82,0.53,0.21,0.31,0.21,0.45,0.49,0.54,0.31,0.49,0.29,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">monia and acute respiratory distress syndrome: a French multicenter </text>
   <text y="345.638" x="71.693,75.683,79.823,82.62,86.258,88.695,92.085,95.49,97.807,99.375,103.365,107.385,110.79,112.38,114.022,117.367,121.357,125.377,129.367,131.775,134.092,135.735,138.532,140.85,144.832,148.912,151.957,153.262,154.905,159.18,160.77,162.337,166.357,168.0,169.695,173.715,175.567,179.205,182.632,184.95,186.592,191.445,193.012,195.727,197.032" svgx:width="0.53,0.55,0.37,0.49,0.29,0.45,0.45,0.31,0.21,0.53,0.54,0.45,0.21,0.22,0.45,0.53,0.54,0.53,0.29,0.31,0.22,0.37,0.31,0.53,0.54,0.44,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">observational cohort study. Clin Infect Dis. </text>
   <text y="345.638" x="198.675,202.695,205.012,207.33,211.47,214.267,214.267,215.572,218.205,220.837,224.917,228.907,230.475,231.78,235.77,237.915,241.995,244.627,248.287,251.947,253.252,256.912,260.572,264.232,267.892,270.525,273.87,275.437,279.517" svgx:width="0.54,0.31,0.31,0.55,0.37,0.22,0.17,0.35,0.35,0.54,0.53,0.21,0.17,0.53,0.29,0.54,0.35,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.35,0.45,0.21,0.54,0.35" style="fill:rgb(0,0,255);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">https ://doi.org/10.1093/cid/</text>
   <text y="354.638" x="71.693,75.038,76.605,79.628,83.288,86.948,86.948" svgx:width="0.45,0.21,0.4,0.49,0.49,0.22,0.49" style="fill:rgb(0,0,255);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ciz90 4</text>
   <text y="363.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,77.588,80.993,83.4,85.8,89.1,90.742,94.057,99.892,101.197,102.577,106.327,107.895,111.975,115.38,116.97,119.205,122.835,126.817,128.385,132.465,135.262,138.9,141.336,144.675,148.312,150.525,152.167,154.642,155.947,157.59,161.865,163.455,166.86,169.132,172.305,173.947,178.222,179.527,181.17,185.85,189.832,193.972,196.29,199.695,201.337,204.817,208.716,210.021,211.664,217.559,221.196,223.461,225.029,229.049,233.039,234.681,238.176,239.481,241.124,245.863,249.268,251.399,255.389,257.706,259.349,263.976,265.281,266.924,271.199,275.219,278.624,282.863" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.78,0.45,0.29,0.31,0.44,0.22,0.46,0.78,0.17,0.22,0.51,0.21,0.54,0.45,0.21,0.3,0.5,0.53,0.21,0.54,0.37,0.49,0.29,0.45,0.49,0.29,0.22,0.34,0.17,0.22,0.57,0.21,0.45,0.29,0.42,0.22,0.57,0.17,0.22,0.62,0.53,0.55,0.31,0.45,0.22,0.46,0.5,0.17,0.22,0.78,0.49,0.29,0.21,0.54,0.53,0.22,0.47,0.17,0.22,0.62,0.45,0.29,0.53,0.31,0.22,0.65,0.17,0.22,0.57,0.54,0.45,0.55,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 18. Marty FM, Vidal-Puigserver J, Clark C, Gupta SK, Merino E, Garot D, Chap-</text>
   <text y="372.638" x="71.693,77.835,81.24,85.26,86.903,92.738,95.212,96.517,98.16,100.747,104.152,107.497,111.487,115.627,118.425,120.067,122.775,124.08,125.722,129.546,133.536,137.616,139.881,141.449,145.529,149.511,153.149,156.171,158.406,163.191,167.181,169.446,171.014,174.651,178.731,182.136,183.779,187.274,188.579,190.221,194.946,198.929,201.726,205.131,206.774,209.504,210.809,212.451,215.931,219.951,223.941,226.349,228.666,230.234,234.254,238.244,239.886,244.513,245.818,247.198,253.138,256.543,258.861,261.658,265.648,269.668,271.311,276.036,280.423,281.728" svgx:width="0.82,0.45,0.54,0.22,0.78,0.34,0.17,0.22,0.34,0.45,0.45,0.53,0.55,0.37,0.22,0.46,0.17,0.22,0.5,0.53,0.54,0.29,0.21,0.54,0.53,0.49,0.4,0.3,0.64,0.53,0.29,0.21,0.49,0.54,0.45,0.22,0.47,0.17,0.22,0.63,0.53,0.37,0.45,0.22,0.5,0.17,0.22,0.46,0.54,0.53,0.29,0.31,0.21,0.54,0.53,0.22,0.65,0.17,0.22,0.82,0.45,0.31,0.37,0.53,0.54,0.22,0.63,0.58,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">man MJ, Jacobs F, Rodriguez-Noriega E, Husa P, Shortino D, Watson HA, </text>
   <text y="381.638" x="71.693,75.045,78.45,80.723,84.36,87.158,88.8,92.025,94.5,95.805,97.447,101.017,104.655,108.795,112.935,116.572,118.702,122.047,126.037,128.302,132.322,133.965,138.352,141.817,143.46,145.447,149.107,152.767,156.427,160.087,162.075,163.717,165.412,169.432,171.75,173.962,177.322,180.66,184.297,188.317,192.307,196.29,199.087,200.73,203.752,207.157,211.177,214.582,220.725,222.292,225.682,227.25,229.462,231.105,235.095,237.307,238.95,242.94,245.152,248.557,250.147,251.79,255.78,258.577,262.215,263.805,266.122,269.527,275.67,277.237,280.627,282.195,284.407" svgx:width="0.5,0.45,0.31,0.49,0.37,0.22,0.5,0.34,0.17,0.22,0.5,0.49,0.55,0.55,0.49,0.29,0.45,0.53,0.29,0.54,0.22,0.58,0.46,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.21,0.54,0.31,0.29,0.45,0.45,0.49,0.54,0.53,0.53,0.37,0.22,0.4,0.45,0.54,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.53,0.29,0.22,0.53,0.29,0.45,0.21,0.22,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Yates PJ, Peppercorn AF (2017) Intravenous zanamivir or oral oseltamivir </text>
   <text y="390.638" x="71.693,73.545,77.535,79.748,81.39,85.41,89.4,92.198,96.338,97.905,100.223,103.628,105.218,106.785,109.583,113.22,117.3,118.943,123.083,126.488,128.805,130.373,134.01,138.03,140.348,143.145,144.788,150.203,151.77,154.088,158.108,159.75,161.318,165.338,168.968,172.95,176.588,180.608,183.63,187.035,188.34,189.983,193.388,197.408,199.05,200.618,204.638,206.91,210.548,212.812,216.832,220.237,222.555,224.122,228.112,232.132,235.537,237.045,238.35,239.992,242.205,245.61,249.63,253.71,257.7,263.842,265.41,268.207,271.845,275.842,277.147" svgx:width="0.26,0.53,0.29,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.21,0.37,0.49,0.54,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.17,0.22,0.45,0.54,0.22,0.21,0.54,0.31,0.49,0.29,0.54,0.45,0.31,0.21,0.53,0.54,0.45,0.21,0.17,0.22,0.29,0.45,0.54,0.54,0.53,0.82,0.21,0.37,0.49,0.54,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">for hospitalised patients with influenza: an international, randomised, </text>
   <text y="399.638" x="71.693,75.773,79.763,83.745,87.885,89.475,93.307,95.542,99.682,101.272,102.84,106.86,110.857,112.162,113.805,117.885,121.875,125.857,129.997,131.587,135.42,137.805,141.885,145.867,152.01,158.077,161.122,162.427,164.07,168.21,172.23,175.635,178.432,182.07,183.712,187.372,189.015,191.332,193.597,195.165,198.57,200.077,201.382,203.025,206.385,209.79,213.81,217.155,220.792,223.11,224.752,228.576,232.214,235.011,239.151,240.719,242.931,244.574,250.469,254.106,258.186,259.829,263.489,264.794,268.454,272.114,275.774,279.524,283.184,286.844" svgx:width="0.54,0.53,0.53,0.55,0.21,0.49,0.3,0.55,0.21,0.21,0.54,0.54,0.17,0.22,0.54,0.53,0.53,0.55,0.21,0.49,0.3,0.54,0.53,0.82,0.82,0.44,0.17,0.22,0.55,0.54,0.45,0.37,0.49,0.22,0.49,0.22,0.31,0.29,0.21,0.45,0.21,0.17,0.22,0.45,0.45,0.54,0.45,0.49,0.31,0.22,0.5,0.49,0.37,0.55,0.21,0.29,0.22,0.78,0.49,0.54,0.22,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">double-blind, double-dummy, phase 3 trial. Lancet Respir Med 5:135–146</text>
   <text y="408.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,75.773,79.41,81.053,83.67,87.66,91.68,95.76,97.403,103.238,107.865,109.17,110.813,112.395,115.193,119.183,123.203,124.845,130.68,135.36,136.665,138.308,144.202,148.192,152.212,154.485,158.475,160.117,164.505,167.985,169.29,170.932,176.827,180.465,182.737,186.404,189.794,191.436,196.161,197.466,199.109,203.384,204.974,208.379,210.651,213.824,215.466,219.741,221.046,222.689,227.803,229.108,233.893,237.531,239.098,240.688,242.331,246.036,247.341,248.983,252.478,254.068,258.148,261.786,263.998,265.641,268.116,269.421" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.54,0.49,0.22,0.34,0.53,0.54,0.54,0.22,0.78,0.65,0.17,0.22,0.21,0.37,0.53,0.54,0.22,0.78,0.62,0.17,0.22,0.78,0.53,0.54,0.31,0.53,0.22,0.58,0.46,0.17,0.22,0.78,0.49,0.31,0.49,0.45,0.22,0.63,0.17,0.22,0.57,0.21,0.45,0.29,0.42,0.22,0.57,0.17,0.22,0.67,0.17,0.64,0.49,0.21,0.21,0.22,0.5,0.17,0.22,0.47,0.21,0.54,0.49,0.29,0.22,0.34,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 19. de Jong MD, Ison MG, Monto AS, Metev H, Clark C, O’Neil B, Elder J, </text>
   <text y="417.638" x="71.693,77.588,80.933,85.155,89.138,90.728,92.318,96.308,100.29,104.37,108.39,110.033,114.42,115.725,117.368,121.598,125.588,127.178,128.768,130.335,133.133,134.775,137.505,138.81,140.453,143.933,147.953,151.59,153.855,155.422,159.502,162.907,166.927,168.307,174.457,178.222,179.865,181.852,185.512,189.172,192.832,196.492,198.48,200.122,203.587,206.977,210.382,211.972,215.955,219.36,221.677,223.245,227.235,231.255,232.897,236.887,238.852,240.495,242.062,246.082,248.4,250.612,253.972,257.31,260.947,264.967,268.957,272.94,275.737" svgx:width="0.78,0.45,0.57,0.53,0.21,0.21,0.53,0.53,0.54,0.54,0.22,0.58,0.17,0.22,0.57,0.53,0.21,0.21,0.21,0.37,0.22,0.5,0.17,0.22,0.46,0.54,0.49,0.29,0.21,0.54,0.45,0.54,0.22,0.82,0.5,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.45,0.45,0.21,0.53,0.45,0.31,0.21,0.53,0.54,0.22,0.53,0.26,0.22,0.21,0.54,0.31,0.29,0.45,0.45,0.49,0.54,0.53,0.53,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">McCullough A, Collis P, Sheridan WP (2014) Evaluation of intravenous </text>
   <text y="426.638" x="71.693,75.833,79.47,81.683,85.088,91.23,92.798,96.188,97.755,99.968,101.61,103.463,107.453,109.665,111.308,113.625,115.755,119.393,122.798,125.115,131.258,134.895,138.915,141.233,142.875,146.865,148.83,150.473,152.04,156.06,159.69,163.673,167.31,171.33,174.353,177.758,179.4,180.968,184.988,186.63,190.65,194.64,197.438,201.578,203.145,205.463,208.868,210.458,212.025,214.988,218.625,222.705,224.348,228.488,231.893,234.21,235.778,239.415,243.435,245.753,248.468,249.773,251.415,255.69,257.28,258.848,262.868,264.51,266.205,270.225,272.077,275.715,279.142,281.46" svgx:width="0.55,0.49,0.29,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.26,0.53,0.29,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.21,0.54,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.21,0.4,0.49,0.54,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">peramivir for treatment of influenza in hospitalized patients. Clin Infect </text>
   <text y="435.638" x="71.693,76.545,78.113,80.91,82.553,86.213,89.873,91.178,94.815,98.475,102.135,105.795,109.695,113.333,116.993,120.653" svgx:width="0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Dis 59:e172–e185</text>
   <text y="444.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,76.418,79.778,83.025,87.105,90.743,94.763,96.405,99.87,104.55,105.855,107.498,110.978,114.998,116.565,120.585,124.665,128.655,130.298,135.083,136.725,138.713,142.373,146.033,149.693,153.353,155.34,156.983,158.678,162.698,166.328,170.31,173.948,177.968,180.99,184.395,186.038,189.428,190.995,193.208,197.19,199.988,201.63,205.77,209.76,211.35,214.65,220.793,224.43,226.643,230.048,232.845,236.483,238.125,239.693,243.713,247.733,249.3,253.44,255.008,257.28,261.27,263.483,266.28,267.923,269.49,273.51,275.153,278.498,280.088,281.655,285.675,287.243" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.63,0.45,0.44,0.54,0.49,0.54,0.22,0.46,0.62,0.17,0.22,0.46,0.54,0.21,0.54,0.54,0.53,0.22,0.64,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.45,0.21,0.29,0.53,0.37,0.22,0.55,0.53,0.21,0.44,0.82,0.49,0.29,0.45,0.37,0.49,0.22,0.21,0.54,0.54,0.21,0.55,0.21,0.31,0.53,0.29,0.37,0.22,0.21,0.54,0.22,0.45,0.21,0.21,0.54,0.21,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 20. Hayden FG, Shindo N (2019) Influenza virus polymerase inhibitors in clini-</text>
   <text y="453.638" x="71.693,75.038,78.443,80.033,81.675,85.755,89.423,92.76,96.398,97.988,101.978,106.118,112.26,115.898,119.918,122.235,123.54,125.183,129.405,133.388,135.652,137.865,139.507,144.54,148.68,150.247,154.267,155.91,157.605,161.625,163.477,167.115,170.541,172.859,174.501,179.354,180.921,183.719,187.356,190.761,193.559,197.196,199.994,201.636,205.296,208.956,210.944,214.604,216.591,217.896,221.556,225.216,228.876,232.626,236.286,239.946" svgx:width="0.45,0.45,0.21,0.22,0.54,0.49,0.45,0.49,0.21,0.53,0.55,0.82,0.49,0.54,0.31,0.17,0.22,0.57,0.53,0.29,0.29,0.22,0.67,0.55,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.49,0.45,0.37,0.49,0.37,0.22,0.49,0.49,0.26,0.49,0.26,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">cal development. Curr Opin Infect Diseases 32(2):176–186</text>
   <text y="462.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,73.275,76.073,80.063,84.083,85.725,91.56,96.24,97.545,99.188,102.758,106.748,109.155,111.472,114.27,120.412,124.402,128.385,130.702,134.722,136.365,139.845,141.15,142.417,145.769,149.759,152.556,156.576,158.144,162.224,165.629,166.896,170.061,171.366,173.009,176.489,180.509,182.076,184.874,188.894,190.461,194.541,198.531,199.859,203.009,204.314,205.956,210.681,214.041,217.289,221.369,225.006,229.026,230.669,233.376,234.681,236.324,241.019,244.656,248.676,252.081,254.294,257.699,259.026,262.514,264.156,266.144,269.804,273.464,277.124,280.784,282.771" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.21,0.37,0.53,0.54,0.22,0.78,0.62,0.17,0.22,0.5,0.53,0.29,0.31,0.37,0.82,0.53,0.53,0.31,0.54,0.22,0.46,0.17,0.22,0.5,0.53,0.37,0.54,0.21,0.54,0.45,0.22,0.5,0.17,0.22,0.46,0.54,0.21,0.37,0.54,0.21,0.54,0.53,0.22,0.47,0.17,0.22,0.63,0.45,0.44,0.54,0.49,0.54,0.22,0.46,0.17,0.22,0.63,0.49,0.54,0.45,0.29,0.45,0.22,0.47,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 21. Ison MG, Portsmouth S, Yoshida Y, Shishido T, Hayden F, Uehara T (2018) </text>
   <text y="471.638" x="71.693,75.053,78.84,82.5,86.16,87.465,89.108,92.813,96.833,100.238,103.035,106.673,108.315,111.975,113.618,115.935,118.2,119.768,123.173,124.763,126.405,130.395,132.36,134.003,138.143,141.548,143.138,147.068,150.285,153.645,157.035,158.603,160.815,162.458,168.6,172.005,174.277,178.417,182.347,185.565,187.132,188.722,190.365,191.932,195.952,197.595,201.615,203.182,207.262,211.282,213.517,215.782,217.35,220.147,223.32,224.962,226.53,230.55,234.18,238.162,241.8,245.82,248.842,252.247,253.89,258.03,261.435,263.752,265.32,268.957,272.977,275.295,278.092" svgx:width="0.45,0.5,0.49,0.49,0.17,0.22,0.5,0.54,0.45,0.37,0.49,0.22,0.49,0.22,0.31,0.29,0.21,0.45,0.21,0.22,0.53,0.26,0.22,0.55,0.45,0.21,0.53,0.43,0.45,0.45,0.21,0.29,0.22,0.82,0.45,0.29,0.55,0.53,0.43,0.21,0.21,0.22,0.21,0.54,0.22,0.54,0.21,0.54,0.54,0.3,0.29,0.21,0.37,0.42,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">LB16. Phase 3 trial of baloxavir marboxil in high-risk influenza patients </text>
   <text y="480.638" x="71.693,73.643,77.918,82.305,86.07,89.55,92.843,97.875,102.66,106.155,108.39,112.05,113.693,116.49,118.808,122.79,126.87,130.17,132.158,133.463,135.105,140.138,144.278,147.915,151.935,153.578,156.788,160.778,162.99,166.973,173.115,174.758,176.453,180.473,182.325,185.962,189.39,191.707,193.35,198.202,199.77,202.567,204.21,207.87,209.175,212.655,216.315,219.975,223.635,227.385,230.865,234.525,238.185" svgx:width="0.26,0.57,0.58,0.5,0.46,0.47,0.67,0.64,0.47,0.3,0.49,0.22,0.37,0.31,0.53,0.54,0.44,0.26,0.17,0.22,0.67,0.55,0.49,0.54,0.22,0.46,0.53,0.29,0.53,0.82,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22,0.49,0.17,0.46,0.49,0.49,0.49,0.5,0.46,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">(CAPSTONE-2 study). Open Forum Infect Dis 5:S764–S765</text>
   <text y="489.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,76.418,80.4,84.42,88.5,90.143,91.725,95.19,99.975,101.28,102.608,105.6,109.59,111.233,114.968,118.883,124.688,125.993,127.635,131.91,135.93,139.335,143.355,144.998,147.585,151.05,156.855,158.16,159.803,164.078,168.098,171.735,175.755,179.835,181.215,185.07,189.225,193.5,194.805,196.447,199.807,201.375,205.357,207.0,210.735,214.215,218.94,220.245,221.572,224.595,228.0,234.142,235.785,240.172,241.477,243.12,247.395,251.415,254.82,258.84,260.167,263.46,267.735,269.04,270.682,274.725,278.745,282.15,286.17,290.25" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.63,0.53,0.54,0.54,0.22,0.21,0.46,0.64,0.17,0.22,0.47,0.53,0.22,0.5,0.5,0.82,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.34,0.46,0.82,0.17,0.22,0.57,0.54,0.49,0.54,0.54,0.22,0.51,0.57,0.57,0.17,0.22,0.45,0.21,0.53,0.22,0.5,0.46,0.63,0.17,0.22,0.47,0.45,0.82,0.22,0.58,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.47,0.57,0.17,0.22,0.54,0.54,0.45,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 22. Hung IFN, To KKW, Chan JFW, Cheng VCC, Liu KSH, Tam A, Chan TC, Zhang </text>
   <text y="498.638" x="71.693,76.245,78.72,80.025,81.668,85.028,86.595,88.238,90.969,92.274,93.654,99.609,103.599,107.619,111.699,113.027,116.514,119.874,121.179,122.822,126.864,130.884,134.289,138.309,142.389,144.032,147.819,149.124,150.767,155.042,159.062,162.699,166.682,170.702,174.782,176.424,182.259,185.994,189.474,190.779,192.422,195.654,199.292,203.274,207.294,211.374,212.754,218.559,219.864,221.507,224.867,228.272,232.254,233.897,236.484,240.257,245.042,246.347,247.989,251.199,255.189,258.361,260.004,265.839,267.144,268.786,273.061,277.081,280.719,284.739" svgx:width="0.58,0.34,0.17,0.22,0.45,0.21,0.22,0.5,0.17,0.22,0.82,0.53,0.54,0.54,0.22,0.47,0.45,0.17,0.22,0.54,0.54,0.45,0.54,0.54,0.22,0.5,0.17,0.22,0.57,0.54,0.49,0.53,0.54,0.54,0.22,0.78,0.5,0.46,0.17,0.22,0.45,0.49,0.53,0.54,0.54,0.22,0.82,0.17,0.22,0.45,0.45,0.53,0.22,0.34,0.5,0.64,0.17,0.22,0.46,0.53,0.42,0.22,0.78,0.17,0.22,0.57,0.54,0.49,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">AJ, Li P, Wong TL, Zhang R, Cheung MKS, Leung W, Lau JYN, Fok M, Chen </text>
   <text y="507.638" x="71.693,76.418,77.723,79.365,83.64,87.66,91.065,95.085,96.728,100.463,105.188,106.493,107.76,111.218,115.2,118.838,122.858,124.5,128.235,132.008,133.65,135.638,139.298,142.958,146.618,150.278,152.265,153.908,157.433,163.155,166.5,169.905,173.393,176.693,178.335,182.325,184.29,185.933,189.278,190.868,194.273,196.538,198.105,200.423,204.443,206.573,210.563,216.63,219.878,223.223,224.79,228.81,231.045,235.065,238.47,242.61,244.74,248.67,251.805,255.443,259.463,261.848,265.838,268.635,272.273,273.863,276.18,279.585,285.728,287.295" svgx:width="0.63,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.63,0.17,0.22,0.5,0.53,0.49,0.54,0.22,0.5,0.5,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.76,0.45,0.45,0.45,0.44,0.22,0.53,0.26,0.22,0.45,0.21,0.45,0.29,0.21,0.31,0.54,0.29,0.53,0.82,0.44,0.45,0.21,0.54,0.3,0.54,0.45,0.55,0.29,0.53,0.43,0.49,0.54,0.3,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">H, Chan KH, Yuen KY (2017) Efficacy of clarithromycin-naproxen-oseltami-</text>
   <text y="516.638" x="71.693,75.083,76.65,78.863,80.505,83.85,87.84,93.983,98.123,99.69,103.71,107.115,109.433,111.0,114.99,119.01,120.653,122.22,126.24,127.883,130.2,134.22,137.858,139.5,141.818,143.948,147.585,150.99,153.308,159.45,163.088,167.108,169.425,171.068,175.058,177.023,178.665,182.805,186.21,188.528,190.095,193.733,197.753,200.07,202.868,204.51,208.53,212.52,215.318,219.458,221.025,223.343,226.748,228.338,229.905,232.868,236.505,240.585,242.228,244.08,248.07,250.283,251.925,253.493,257.513,261.143,265.125,268.763,272.783,275.805,279.21" svgx:width="0.45,0.21,0.29,0.22,0.45,0.53,0.82,0.55,0.21,0.54,0.45,0.31,0.21,0.53,0.54,0.22,0.21,0.54,0.22,0.31,0.54,0.49,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.21,0.4,0.49,0.54,0.22,0.26,0.53,0.29,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">vir combination in the treatment of patients hospitalized for influenza </text>
   <text y="525.638" x="71.693,76.08,78.068,82.793,86.453,91.238,94.898,96.885,98.528,100.095,104.115,105.968,109.605,113.033,115.35,116.918,120.908,124.928,126.233,127.875,131.28,135.3,136.943,140.933,145.073,148.71,152.73,154.965,156.555,159.96,164.1,167.738,169.328,170.97,173.183,176.588,180.608,184.688,188.678,194.82,196.388,199.35,202.988,206.985,208.29,209.933,213.278,217.268,221.288,223.605,225.735,229.725,231.315,232.905,236.543,240.54,241.845,243.488,247.628,251.648,255.053,257.85,261.488,263.13,264.713,266.407,270.547,273.18,274.762,276.345,277.927" svgx:width="0.58,0.26,0.63,0.49,0.64,0.49,0.26,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.17,0.22,0.45,0.54,0.22,0.53,0.55,0.49,0.54,0.3,0.21,0.45,0.55,0.49,0.21,0.22,0.29,0.45,0.54,0.54,0.53,0.82,0.21,0.4,0.49,0.54,0.17,0.22,0.45,0.53,0.54,0.31,0.29,0.53,0.21,0.21,0.49,0.54,0.17,0.22,0.55,0.54,0.45,0.37,0.49,0.22,0.21,0.21,0.55,0.35,0.21,0.21,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">A(H3N2) infection: an open-label randomized, controlled, phase IIb/III </text>
   <text y="534.638" x="71.693,74.01,76.275,77.843,81.248,82.755,84.06,85.703,89.978,93.998,97.635,100.433,102.75,104.393,108.053,111.713,115.373,116.678,120.338,123.998,127.658,131.318,135.068,138.728,142.388,146.048" svgx:width="0.31,0.29,0.21,0.45,0.21,0.17,0.22,0.57,0.54,0.49,0.37,0.31,0.22,0.49,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">trial. Chest 151:1069–1080</text>
   <text y="543.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,77.588,80.993,83.4,85.718,87.285,91.305,93.54,96.773,100.763,104.4,107.745,111.765,115.403,118.2,119.843,121.425,122.73,124.373,128.16,131.798,134.062,140.205,143.842,145.447,149.542,151.777,157.672,161.077,163.484,165.801,167.369,171.389,173.031,175.619,178.326,179.631,181.011,184.619,188.024,189.614,191.204,194.841,197.639,199.281,201.756,203.061,204.703,209.383,211.596,215.001,219.021,222.426,226.506,229.911,231.553,235.341,236.646,238.026,241.776,243.343,247.423,250.828,254.811,257.023,258.666,262.026,263.331,264.711,268.333,271.971,274.116,278.196,281.601,283.813,287.218" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.78,0.45,0.29,0.31,0.21,0.54,0.3,0.45,0.53,0.49,0.45,0.54,0.49,0.37,0.22,0.21,0.17,0.22,0.5,0.49,0.29,0.82,0.49,0.21,0.53,0.3,0.78,0.45,0.29,0.31,0.21,0.54,0.22,0.34,0.46,0.17,0.22,0.51,0.45,0.21,0.21,0.49,0.37,0.22,0.34,0.17,0.22,0.62,0.29,0.45,0.54,0.45,0.54,0.45,0.22,0.5,0.17,0.22,0.51,0.21,0.54,0.45,0.53,0.29,0.22,0.45,0.17,0.22,0.51,0.49,0.29,0.54,0.45,0.29,0.45,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 23. Martin-Loeches I, Bermejo-Martin JF, Valles J, Granada R, Vidaur L, Vergara-</text>
   <text y="552.638" x="71.693,75.21,78.848,81.112,83.325,86.73,90.75,94.74,96.382,98.97,103.245,104.55,106.192,112.087,115.492,117.9,120.217,121.785,125.805,127.447,133.282,134.587,136.23,139.47,141.037,145.117,149.1,152.737,154.305,156.517,159.922,161.565,164.152,168.427,169.732,171.375,174.855,176.422,178.86,182.197,185.835,189.855,192.172,193.815,196.402,202.237,203.542,205.185,208.972,210.562,213.967,217.987,222.052,226.035,229.672,231.885,233.527,236.002,237.307,238.95,242.43,246.412,249.817,251.947,255.585,258.607,260.25,264.877,266.182" svgx:width="0.46,0.49,0.29,0.29,0.45,0.54,0.53,0.22,0.34,0.57,0.17,0.22,0.78,0.45,0.29,0.31,0.21,0.54,0.22,0.78,0.17,0.22,0.46,0.21,0.54,0.53,0.49,0.21,0.29,0.45,0.22,0.34,0.57,0.17,0.22,0.46,0.21,0.29,0.45,0.49,0.54,0.31,0.22,0.34,0.78,0.17,0.22,0.5,0.21,0.45,0.54,0.54,0.53,0.49,0.29,0.22,0.34,0.17,0.22,0.46,0.53,0.45,0.29,0.49,0.4,0.22,0.65,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Serrano JC, Martin M, Figueira JC, Sirvent JM, Blanquer J, Suarez D, </text>
   <text y="561.638" x="71.693,76.08,78.488,80.805,82.373,86.453,89.858,92.655,94.298,98.685,99.99,101.318,104.31,108.3,110.565,112.695,116.333,119.13,120.773,125.16,126.465,128.108,132.96,134.528,137.933,140.955,142.598,146.093,147.398,149.04,152.865,156.855,160.935,163.2,164.768,168.848,172.83,176.468,179.49,181.133,185.52,187.163,189.15,192.81,196.47,200.13,203.79,205.778,207.42,213.315,216.72,220.065,222.195,226.185,227.775,229.342,233.422,237.255,239.49,243.63,247.035,249.832,253.47,257.55,259.192,261.322,264.96,268.98,270.547,276.69,280.327,284.347,287.145" svgx:width="0.58,0.29,0.31,0.21,0.54,0.45,0.37,0.22,0.58,0.17,0.22,0.47,0.53,0.29,0.29,0.49,0.37,0.22,0.58,0.17,0.22,0.65,0.21,0.45,0.4,0.22,0.47,0.17,0.22,0.5,0.53,0.54,0.29,0.21,0.54,0.53,0.49,0.4,0.22,0.58,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.78,0.45,0.45,0.29,0.53,0.21,0.21,0.54,0.49,0.3,0.55,0.45,0.37,0.49,0.54,0.22,0.29,0.49,0.54,0.21,0.82,0.49,0.54,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Artigas A, Torres A, Diaz E, Rodriguez A (2013) Macrolide-based regimens </text>
   <text y="570.638" x="71.693,73.26,77.28,78.923,82.328,86.468,89.265,92.903,96.923,100.268,103.905,105.548,109.538,111.503,113.145,117.285,120.69,124.118,126.39,130.027,132.292,133.86,137.265,138.855,140.497,143.842,147.937,150.172,151.74,155.76,157.612,161.25,164.676,166.994,168.561,172.551,176.571,178.214,179.781,183.801,185.444,188.789,191.054,192.621,194.939,196.506,199.851,203.256,204.846,206.436,209.736,211.379,212.946,214.536,216.126,217.769,222.494,226.154,230.939,234.599,236.241,240.381,243.786,246.104,247.671,251.309,255.329,257.646,260.444,262.086,267.501,269.069,271.386,275.406" svgx:width="0.21,0.54,0.22,0.45,0.55,0.37,0.49,0.54,0.45,0.49,0.22,0.53,0.26,0.22,0.55,0.45,0.45,0.31,0.49,0.29,0.21,0.45,0.21,0.22,0.45,0.53,0.3,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.22,0.21,0.54,0.22,0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.21,0.21,0.21,0.22,0.63,0.49,0.64,0.49,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">in absence of bacterial co-infection in critically ill H1N1 patients with </text>
   <text y="579.638" x="71.693,75.833,78.098,79.665,85.808,89.213,91.65,94.95,96.592,99.982,101.55,103.762,107.167,108.757,110.4,114.54,118.56,122.197,126.18,132.322,136.312,140.332,141.9,145.305,146.61,148.252,149.947,153.967,156.24,159.877,163.897,166.695,168.262,171.6,175.237,176.88,181.124,184.529,186.659,190.296,191.939,197.834,201.471,205.551,207.194,210.854,214.514,215.819,219.479,223.139,226.799,230.549,234.209,237.869" svgx:width="0.55,0.29,0.21,0.82,0.45,0.29,0.44,0.22,0.45,0.21,0.29,0.45,0.21,0.22,0.55,0.54,0.49,0.53,0.82,0.53,0.54,0.21,0.45,0.17,0.22,0.21,0.54,0.31,0.49,0.54,0.37,0.21,0.45,0.49,0.22,0.57,0.45,0.29,0.49,0.22,0.78,0.49,0.54,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">primary viral pneumonia. Intensive Care Med 39:693–702</text>
   <text y="588.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,76.08,78.293,81.698,85.838,87.405,88.673,92.415,98.25,99.555,101.198,106.095,109.732,113.37,117.51,119.152,123.495,129.33,130.635,132.277,136.665,138.255,140.49,145.215,148.62,154.762,158.4,162.037,166.117,167.76,170.467,171.772,173.415,179.309,182.714,186.734,190.814,194.804,198.786,200.999,204.404,208.424,209.691,212.856,214.161,215.804,220.191,221.781,227.924,231.561,234.899,238.919,240.509,243.914,247.544,249.186,253.866,258.254,259.559,261.201,264.681,266.249,270.269,274.349,275.916" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.58,0.29,0.45,0.55,0.21,0.22,0.5,0.78,0.17,0.22,0.65,0.49,0.49,0.55,0.22,0.58,0.78,0.17,0.22,0.58,0.21,0.3,0.63,0.45,0.82,0.49,0.49,0.54,0.22,0.46,0.17,0.22,0.78,0.45,0.54,0.54,0.53,0.53,0.29,0.45,0.54,0.22,0.5,0.17,0.22,0.58,0.21,0.82,0.49,0.42,0.54,0.21,0.45,0.48,0.22,0.62,0.58,0.17,0.22,0.46,0.21,0.54,0.54,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 24. Arabi YM, Deeb AM, Al-Hameed F, Mandourah Y, Almekhlafi GA, Sindi </text>
   <text y="597.638" x="71.693,76.08,80.468,81.773,83.415,87.803,89.393,91.74,96.772,102.915,106.32,108.585,110.152,111.795,116.182,117.487,119.13,122.61,126.63,130.035,131.625,135.645,139.635,143.617,147.757,149.4,152.88,154.185,155.827,161.722,165.127,169.207,172.507,174.15,178.537,179.842,181.485,185.872,187.462,189.675,193.08,197.16,201.24,204.645,208.725,210.292,211.935,215.64,216.945,218.587,222.975,224.565,230.707,234.697,237.015,240.42,241.987,244.252,245.82,247.462,251.85,253.155,254.797,259.185,260.775,262.417,266.272,270.292,273.697,276.015,277.582,281.722" svgx:width="0.58,0.58,0.17,0.22,0.58,0.21,0.3,0.67,0.82,0.45,0.29,0.21,0.22,0.58,0.17,0.22,0.46,0.54,0.45,0.21,0.54,0.53,0.53,0.55,0.22,0.46,0.17,0.22,0.78,0.45,0.54,0.44,0.22,0.58,0.17,0.22,0.58,0.21,0.29,0.45,0.54,0.54,0.45,0.54,0.21,0.22,0.5,0.17,0.22,0.58,0.21,0.82,0.53,0.31,0.45,0.21,0.29,0.21,0.22,0.58,0.17,0.22,0.58,0.21,0.22,0.5,0.54,0.45,0.31,0.21,0.55,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">AA, Al-Omari A, Shalhoub S, Mady A, Alraddadi B, Almotairi A, Al Khatib </text>
   <text y="606.638" x="71.693,75.593,76.898,78.54,82.928,87.068,91.148,95.13,96.72,102.863,106.853,112.995,116.633,120.653,122.295,126.683,127.988,129.63,134.663,138.645,141.443,145.463,151.605,155.01,159.075,160.718,162.3,163.605,165.248,168.765,172.755,174.345,177.75,179.318,185.46,188.865,192.885,194.528,199.335,200.64,202.283,206.67,208.26,210.495,214.883,216.45,218.768,222.788,226.193,230.213,231.855,236.198,242.033,243.338,244.98,249.368,250.958,253.193,257.085,260.49,264.57,268.65,272.055,276.135,277.703" svgx:width="0.5,0.17,0.22,0.58,0.55,0.54,0.53,0.21,0.82,0.53,0.82,0.49,0.54,0.22,0.58,0.17,0.22,0.67,0.53,0.37,0.54,0.82,0.45,0.54,0.22,0.21,0.17,0.22,0.46,0.53,0.21,0.45,0.21,0.82,0.45,0.54,0.22,0.67,0.17,0.22,0.58,0.21,0.3,0.58,0.21,0.31,0.54,0.45,0.54,0.22,0.58,0.78,0.17,0.22,0.58,0.21,0.3,0.5,0.45,0.54,0.54,0.45,0.54,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">K, Abdulmomen A, Qushmaq I, Solaiman O, Al-Aithan AM, Al-Raddadi </text>
   <text y="615.638" x="71.693,75.48,76.785,78.428,82.32,85.725,89.805,93.21,97.35,98.993,103.38,104.685,106.328,110.715,112.305,113.948,118.673,122.078,124.485,126.802,130.747,134.047,135.69,140.077,141.382,143.025,146.88,150.9,154.305,156.517,159.922,164.062,167.467,169.11,173.497,174.802,176.445,179.062,183.052,185.85,189.487,191.13,193.604,194.909,196.551,201.404,204.809,208.949,213.089,216.494,220.574,224.594,225.922,229.072,230.377,232.02,235.23,239.182,244.597,246.187,249.825,252.037,253.68,257.467,261.855,263.16,264.802,268.59,271.995,273.585,276.922,280.867,284.167" svgx:width="0.5,0.17,0.22,0.5,0.45,0.54,0.45,0.55,0.22,0.58,0.17,0.22,0.58,0.21,0.22,0.63,0.45,0.29,0.31,0.54,0.44,0.22,0.58,0.17,0.22,0.5,0.54,0.45,0.29,0.45,0.55,0.45,0.22,0.58,0.17,0.22,0.34,0.53,0.37,0.49,0.22,0.34,0.17,0.22,0.65,0.45,0.55,0.55,0.45,0.54,0.54,0.22,0.47,0.17,0.22,0.46,0.53,0.72,0.21,0.49,0.29,0.22,0.5,0.58,0.17,0.22,0.5,0.45,0.21,0.42,0.54,0.44,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">R, Ragab A, Al Harthy A, Kharaba A, Jose J, Dabbagh T, Fowler RA, Balkhy </text>
   <text y="624.638" x="71.693,76.418,81.143,82.448,84.09,89.985,93.623,95.835,98.633,102.623,106.643,108.285,111.645,112.95,114.593,119.318,122.678,125.925,130.005,133.643,137.663,139.305,142.77,147.45,148.755,150.398,153.878,157.283,161.265,165.345,166.913,168.555,172.83,175.095,176.662,178.98,180.547,183.892,187.297,188.887,190.53,194.775,198.18,200.31,203.947,205.275,208.462,210.727,212.295,215.7,217.29,220.087,221.73,225.81,227.452,229.44,233.1,236.76,240.42,244.08,246.067,247.71,253.605,257.01,260.355,262.485,266.475,268.065,269.632,273.712,277.35,280.147,281.79,283.357,287.377" svgx:width="0.63,0.63,0.17,0.22,0.78,0.49,0.29,0.37,0.53,0.54,0.22,0.45,0.17,0.22,0.63,0.45,0.44,0.54,0.49,0.54,0.22,0.46,0.62,0.17,0.22,0.46,0.45,0.53,0.54,0.21,0.22,0.57,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22,0.57,0.45,0.29,0.49,0.22,0.47,0.29,0.21,0.45,0.21,0.37,0.22,0.54,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.78,0.45,0.45,0.29,0.53,0.21,0.21,0.54,0.49,0.37,0.22,0.21,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">HH, Merson L, Hayden FG, Saudi Critical Care Trials g (2019) Macrolides in </text>
   <text y="633.638" x="71.693,75.038,77.303,78.87,81.188,82.755,86.1,89.505,91.095,92.685,95.985,97.628,99.195,100.785,102.375,104.018,108.158,111.563,113.88,115.448,119.085,123.105,125.423,128.22,129.863,135.278,136.845,139.163,143.183,144.825,150.78,152.348,156.428,160.508,162.098,165.735,167.378,170.873,174.278,177.075,179.393,181.035,184.86,188.497,191.295,195.435,197.002,199.215,202.62,204.892,208.882,211.32,214.62,216.262,219.742,223.042,227.062,231.142,233.272,237.262,243.405,246.967,248.272,249.915,251.61,255.63,257.947,259.59,262.177,263.82,265.515,269.535,271.387,275.025,278.452,280.77" svgx:width="0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.21,0.21,0.21,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22,0.78,0.21,0.54,0.54,0.21,0.49,0.22,0.47,0.45,0.37,0.31,0.22,0.5,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.46,0.44,0.54,0.54,0.29,0.53,0.82,0.49,0.17,0.22,0.21,0.54,0.31,0.22,0.34,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">critically ill patients with Middle East Respiratory Syndrome. Int J Infect </text>
   <text y="642.638" x="71.693,76.545,78.113,80.91,82.553,86.213,89.873,91.178,94.838,98.498,102.158,105.908,109.568,113.228" svgx:width="0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Dis 81:184–190</text>
   <text y="651.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,76.418,79.823,83.843,85.485,89.385,90.69,92.332,98.227,101.632,103.275,108.0,109.305,110.947,115.335,119.355,120.997,125.092,126.397,128.04,131.52,135.502,136.77,139.935,141.24,142.882,147.157,151.177,154.815,158.835,160.477,162.952,164.257,165.9,169.26,170.827,174.232,178.252,179.895,183.937,185.242,186.885,190.927,194.947,198.352,202.342,203.985,206.46,207.765,209.407,213.45,217.47,221.452,223.095,226.882,229.612,230.917,232.56,235.77,239.76,243.78,246.097,249.502,251.07,255.09,258.727,260.37,264.157,267.652,268.957,270.6,273.81,277.447,281.467,285.547" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.63,0.45,0.54,0.22,0.5,0.17,0.22,0.78,0.45,0.22,0.63,0.17,0.22,0.58,0.54,0.22,0.55,0.17,0.22,0.46,0.53,0.22,0.5,0.17,0.22,0.57,0.54,0.49,0.54,0.22,0.34,0.17,0.22,0.45,0.21,0.45,0.54,0.22,0.54,0.17,0.22,0.54,0.54,0.45,0.53,0.22,0.34,0.17,0.22,0.54,0.54,0.53,0.22,0.5,0.5,0.17,0.22,0.46,0.53,0.54,0.31,0.45,0.21,0.54,0.49,0.22,0.5,0.47,0.17,0.22,0.46,0.49,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 25. Han K, Ma H, An X, Su Y, Chen J, Lian Z, Zhao J, Zhu BP, Fontaine RE, Feng </text>
   <text y="660.638" x="71.693,75.735,77.04,78.683,82.62,86.258,90.278,94.358,96.0,100.68,102.323,104.31,107.97,111.63,115.29,118.95,120.938,122.58,126.075,129.48,131.752,133.342,136.642,138.285,142.267,145.065,148.702,150.345,154.335,156.3,157.942,162.022,163.612,167.595,170.94,174.93,178.275,182.265,184.672,186.99,188.557,191.902,195.892,197.46,201.54,204.337,205.98,211.395,214.8,217.597,219.24,222.645,224.287,226.552,228.12,230.917,234.09,235.732,237.697,241.102,244.53,246.802,250.792,253.005,254.647,256.5,260.49,262.702,264.345,267.69,269.955,271.522,273.84,275.407,278.752,282.157,283.747" svgx:width="0.54,0.17,0.22,0.54,0.49,0.54,0.54,0.22,0.62,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.45,0.29,0.21,0.44,0.22,0.53,0.37,0.49,0.22,0.53,0.26,0.22,0.54,0.21,0.53,0.45,0.53,0.45,0.53,0.29,0.31,0.21,0.45,0.53,0.21,0.54,0.37,0.22,0.72,0.45,0.37,0.22,0.45,0.22,0.29,0.21,0.37,0.42,0.22,0.26,0.45,0.45,0.31,0.53,0.29,0.22,0.26,0.53,0.29,0.22,0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Z, Zeng G (2011) Early use of glucocorticoids was a risk factor for critical </text>
   <text y="669.638" x="71.693,75.773,77.34,80.138,83.775,87.18,89.978,93.615,95.258,98.663,102.683,106.763,108.405,112.485,116.123,119.528,121.845,125.865,127.508,129.473,131.602,135.592,141.735,143.377,147.517,152.242,155.902,160.687,164.347,165.99,167.557,171.577,173.429,177.066,180.494,182.811,184.379,188.369,192.389,193.694,195.336,199.611,201.201,202.769,206.789,208.431,210.126,214.146,215.998,219.636,223.063,225.381,227.023,231.876,233.443,236.241,237.883,241.543,245.203,246.508,250.168,253.828,257.488,261.238,264.898,268.558" svgx:width="0.54,0.21,0.37,0.49,0.45,0.37,0.49,0.22,0.45,0.54,0.54,0.22,0.54,0.49,0.45,0.31,0.54,0.22,0.26,0.29,0.53,0.82,0.22,0.55,0.63,0.49,0.64,0.49,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">disease and death from pH1N1 infection. Clin Infect Dis 53:326–333</text>
   <text y="678.638" x="56.693,57.69,61.35,65.01,66.315,67.965,71.693,76.59,80.228,81.818,85.223,89.243,92.91,96.21,97.853,100.44,106.245,107.55,109.193,112.8,114.368,118.388,120.66,124.65,126.293,130.08,131.385,133.028,136.26,140.25,144.27,148.35,149.993,152.468,153.773,155.415,158.775,162.18,168.323,172.313,176.333,178.65,182.055,186.075,190.095,193.733,195.375,198.083,199.388,201.03,205.343,209.423,213.443,215.01,218.377,221.782,224.047,225.615,227.257,232.042,235.942,237.247,238.89,242.625,246.607,252.75,256.155,258.367,260.01,264.397,265.702,267.345,273.24,276.645,278.79" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.65,0.49,0.21,0.45,0.54,0.49,0.44,0.22,0.34,0.82,0.17,0.22,0.5,0.21,0.54,0.31,0.53,0.22,0.5,0.17,0.22,0.45,0.53,0.54,0.54,0.22,0.34,0.17,0.22,0.45,0.45,0.82,0.53,0.54,0.31,0.45,0.54,0.54,0.49,0.22,0.46,0.17,0.22,0.58,0.54,0.54,0.21,0.42,0.45,0.29,0.21,0.22,0.64,0.5,0.17,0.22,0.5,0.53,0.82,0.45,0.29,0.22,0.58,0.17,0.22,0.78,0.45,0.29,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 26. Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, Mar-</text>
   <text y="687.638" x="71.693,74.49,78.51,81.915,83.505,85.095,86.738,89.325,93.6,94.905,96.548,100.778,104.768,108.758,111.93,113.573,118.425,120.9,122.205,123.848,126.465,130.455,134.437,137.775,141.412,143.73,145.372,148.102,149.407,151.05,154.26,157.897,160.042,164.122,168.105,170.902,174.892,178.912,180.555,185.34,189.967,191.272,192.915,197.595,199.86,201.427,205.065,207.862,211.942,215.347,216.937,220.575,222.217,226.845,228.15,229.792,233.58,237.562,239.827,242.265,245.565,247.207,250.567,255.195,256.5,258.142,261.93,265.912,268.177,272.197,274.995,276.637,280.372,283.867,285.172" svgx:width="0.37,0.54,0.45,0.21,0.21,0.22,0.34,0.57,0.17,0.22,0.57,0.53,0.53,0.42,0.22,0.65,0.34,0.17,0.22,0.34,0.53,0.53,0.45,0.49,0.31,0.22,0.5,0.17,0.22,0.46,0.49,0.29,0.54,0.53,0.37,0.53,0.54,0.22,0.64,0.65,0.17,0.22,0.62,0.29,0.21,0.49,0.37,0.54,0.45,0.21,0.49,0.22,0.65,0.17,0.22,0.5,0.53,0.29,0.29,0.44,0.22,0.45,0.65,0.17,0.22,0.5,0.53,0.29,0.54,0.37,0.22,0.5,0.47,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">shall JC, Cook DJ, Jouvet P, Ferguson ND, Griesdale D, Burry LD, Burns KE, </text>
   <text y="696.638" x="71.693,76.418,80.4,82.673,86.018,90.038,91.605,94.403,98.393,102.413,104.055,106.53,107.835,109.478,115.373,119.01,123.03,125.348,128.753,130.395,133.875,135.18,136.823,142.717,146.355,150.375,154.365,158.385,160.027,163.927,165.232,166.875,170.085,174.037,179.452,181.042,184.68,186.892,188.535,192.322,196.71,198.015,199.657,203.902,207.307,211.327,214.732,218.812,220.38,223.785,227.805,229.447,233.722,235.987,237.555,239.872,241.44,244.785,248.19,249.78,251.422,255.667,259.072,261.202,264.84,266.167,269.355,271.619,273.186,276.591,278.181,280.979" svgx:width="0.63,0.53,0.31,0.45,0.54,0.21,0.37,0.53,0.54,0.22,0.34,0.17,0.22,0.78,0.49,0.54,0.31,0.45,0.22,0.46,0.17,0.22,0.78,0.49,0.54,0.53,0.54,0.22,0.5,0.17,0.22,0.46,0.53,0.72,0.21,0.49,0.29,0.22,0.5,0.58,0.17,0.22,0.57,0.45,0.54,0.45,0.54,0.21,0.45,0.54,0.22,0.57,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22,0.57,0.45,0.29,0.49,0.22,0.47,0.29,0.21,0.45,0.21,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Hutchison J, Mehta S, Menon K, Fowler RA, Canadian Critical Care Trials </text>
   <text y="705.638" x="71.693,76.373,78.503,82.493,86.475,90.615,92.258,96.983,101.768,106.043,107.685,109.673,113.333,116.993,120.653,124.313,126.3,127.628,131.085,135.105,138.743,140.385,141.953,145.973,149.603,153.585,157.223,161.243,164.588,168.225,169.868,173.858,175.823,177.465,180.81,184.8,187.207,189.525,191.092,194.437,198.427,201.225,203.497,207.135,209.265,213.255,214.822,218.902,220.545,222.862,224.992,228.63,232.035,234.352,240.495,244.132,248.152,250.47,252.112,256.102,260.122,261.765,264.082,268.102,271.74,273.382,277.372,281.355,283.613" svgx:width="0.62,0.29,0.53,0.53,0.55,0.22,0.63,0.64,0.57,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.54,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.45,0.49,0.22,0.53,0.26,0.22,0.45,0.53,0.29,0.31,0.21,0.45,0.53,0.37,0.31,0.49,0.29,0.53,0.21,0.54,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.54,0.22,0.31,0.54,0.49,0.22,0.53,0.53,0.31,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Group HNC (2016) The influence of corticosteroid treatment on the out-</text>
   <text y="714.638" x="71.693,75.038,79.028,85.17,88.808,90.45,94.44,96.405,98.048,99.615,103.635,107.265,111.248,114.885,118.905,121.928,125.333,126.975,131.363,133.35,138.075,141.735,146.52,150.18,154.32,158.4,164.543,168.203,171.863,173.85,176.085,178.215,181.853,183.443,186.848,189.12,192.758,196.838,198.48,201.825,204.09,205.658,207.975,209.543,212.888,216.293,217.883,219.525,221.093,222.683,224.273,228.293,231.93,234.728,237.443,238.748,240.39,244.665,246.93,248.497,250.815,252.457,256.701,260.106,262.236,265.874,267.516,271.176,274.836,276.141,279.801" svgx:width="0.45,0.53,0.82,0.49,0.22,0.53,0.26,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.58,0.26,0.63,0.49,0.64,0.49,0.55,0.54,0.82,0.49,0.49,0.26,0.3,0.29,0.49,0.21,0.45,0.31,0.49,0.54,0.22,0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22,0.21,0.21,0.21,0.54,0.49,0.37,0.37,0.17,0.22,0.57,0.29,0.21,0.31,0.22,0.57,0.45,0.29,0.49,0.22,0.49,0.49,0.17,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">come of influenza A(H1N1pdm09)-related critical illness. Crit Care 20:75</text>
   <text y="93.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,322.958,326.595,330.233,331.875,335.34,338.835,340.14,341.52,347.46,350.865,352.455,355.253,359.273,360.915,364.41,367.905,369.21,370.853,373.95,377.355,378.945,381.742,385.41,388.71,390.352,394.74,398.527,400.169,402.157,405.817,409.477,413.137,416.797,418.784,420.112,423.569,427.589,431.227,432.869,436.507,440.459,444.097,447.524,449.841,451.484,455.474,457.439,459.081,461.879,464.151,467.789,469.919,473.909,475.476,479.556,481.199,485.181,487.979,491.616,493.259,494.826,498.846,500.489,504.509,508.499,511.296,515.436,517.004,519.321,522.726,524.316,525.884,528.846,532.484,536.564" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.45,0.49,0.49,0.22,0.46,0.47,0.17,0.22,0.82,0.45,0.21,0.37,0.54,0.22,0.47,0.47,0.17,0.22,0.46,0.45,0.21,0.37,0.49,0.44,0.22,0.58,0.5,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.54,0.49,0.22,0.49,0.54,0.49,0.45,0.31,0.22,0.53,0.26,0.22,0.37,0.31,0.49,0.29,0.53,0.21,0.54,0.22,0.53,0.37,0.49,0.22,0.21,0.54,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.21,0.4,0.49,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 27. Lee FE, Walsh EE, Falsey AR (2011) The effect of steroid use in hospitalized </text>
   <text y="102.638" x="319.725,323.13,327.21,331.193,332.783,335.1,337.898,339.495,344.91,346.478,348.795,352.815,354.413,356.543,360.18,362.978,367.118,368.685,370.898,374.303,376.575,380.565,383.003,386.303,387.9,390.698,393.998,398.018,401.505,404.805,407.123,408.69,412.095,413.685,415.283,418.673,420.24,422.453,426.435,429.233,431.468,433.598,437.235,438.825,442.23,444.503,448.14,452.22,453.818,455.385,456.975,458.565,462.585,466.223,469.02,471.735,473.04,474.637,478.912,482.932,486.57,489.367,491.685,493.282,496.942,500.602,504.262,505.567,509.227,512.887,516.547,520.207,523.957,527.617,531.277,534.937" svgx:width="0.45,0.54,0.53,0.21,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.37,0.44,0.54,0.45,0.44,0.31,0.21,0.45,0.21,0.22,0.45,0.21,0.29,0.53,0.37,0.3,0.29,0.49,0.21,0.45,0.31,0.49,0.54,0.22,0.21,0.21,0.21,0.54,0.49,0.37,0.37,0.17,0.22,0.57,0.54,0.49,0.37,0.31,0.22,0.49,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">adults with respiratory syncytial virus-related illness. Chest 140:1155–1161</text>
   <text y="111.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,322.958,326.595,330.233,331.875,336.66,337.965,339.608,343.995,345.585,347.175,350.813,354.833,356.475,360.75,364.77,368.175,372.195,373.838,377.527,381.802,383.107,384.75,389.475,393.457,395.025,396.667,401.52,405.0,406.305,407.947,412.732,416.812,418.455,421.95,425.85,427.155,428.534,434.609,438.592,440.234,444.622,445.927,447.569,451.844,455.864,457.432,461.414,463.057,467.062,472.867,474.172,475.552,481.507,485.497,489.517,493.597,494.977,498.959,504.764,506.069,507.712,511.987,516.007,519.412,523.432,525.074,528.839,532.739,534.044" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.45,0.49,0.49,0.22,0.64,0.17,0.22,0.58,0.21,0.21,0.49,0.54,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.57,0.17,0.22,0.63,0.53,0.21,0.22,0.65,0.46,0.17,0.22,0.64,0.54,0.22,0.47,0.5,0.17,0.22,0.82,0.53,0.22,0.58,0.17,0.22,0.57,0.54,0.21,0.53,0.22,0.5,0.82,0.17,0.22,0.82,0.53,0.54,0.54,0.22,0.51,0.82,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.5,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 28. Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, Wong VW, Chan PK, </text>
   <text y="120.638" x="319.725,325.68,329.67,333.69,337.77,339.413,343.373,346.523,347.828,349.208,355.163,359.153,363.173,367.253,368.895,372.39,373.695,375.338,379.568,383.558,386.903,390.24,392.453,395.858,402.0,403.643,407.918,411.398,412.703,414.03,417.053,420.458,426.6,428.243,430.83,434.31,435.615,437.258,440.738,444.72,448.74,452.82,454.463,457.05,459.525,460.83,462.473,465.705,469.695,470.962,474.705,480.54,482.182,484.17,487.83,491.49,495.15,498.81,500.797,502.44,505.965,509.917,513.555,516.982,519.3,522.097,523.74,527.73,529.695" svgx:width="0.82,0.53,0.54,0.54,0.22,0.5,0.47,0.17,0.22,0.82,0.53,0.54,0.54,0.22,0.47,0.17,0.22,0.57,0.53,0.45,0.42,0.29,0.45,0.82,0.22,0.57,0.46,0.17,0.22,0.47,0.45,0.82,0.22,0.34,0.46,0.17,0.22,0.46,0.53,0.54,0.54,0.22,0.34,0.34,0.17,0.22,0.45,0.53,0.22,0.5,0.78,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.54,0.49,0.45,0.31,0.37,0.22,0.53,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Wong KT, Wong E, Cockram CS, Tam JS, Sung JJ, Lo YM (2004) Effects of </text>
   <text y="129.638" x="319.725,323.363,326.768,329.04,330.63,333.93,335.573,338.918,342.908,345.315,347.633,349.2,352.545,356.535,359.333,361.605,365.243,367.373,371.363,372.93,377.01,378.653,380.97,383.1,386.738,390.143,392.46,398.603,402.24,406.26,408.578,410.22,414.21,418.23,419.873,424.013,425.603,429.008,431.805,437.948,441.353,442.995,446.475,450.863,454.65,458.13,460.365,463.77,466.568,469.365,473.355,476.7,478.268,481.673,483.945,487.583,491.663,493.305,497.535,501.525,503.655,507.645,511.665,515.024,518.414,519.982,522.194,526.177,528.974" svgx:width="0.49,0.45,0.29,0.21,0.44,0.22,0.45,0.53,0.29,0.31,0.21,0.45,0.53,0.37,0.31,0.49,0.29,0.53,0.21,0.54,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.54,0.22,0.55,0.21,0.45,0.37,0.82,0.45,0.22,0.46,0.58,0.5,0.46,0.3,0.45,0.37,0.37,0.53,0.45,0.21,0.45,0.31,0.49,0.54,0.22,0.57,0.53,0.29,0.53,0.54,0.45,0.45,0.21,0.29,0.53,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">early corticosteroid treatment on plasma SARS-associated Coronavirus </text>
   <text y="138.638" x="319.725,323.513,328.298,332.685,334.328,337.673,341.663,345.683,349.028,352.665,356.685,359.003,361.215,364.62,366.938,368.505,372.495,376.515,379.313,380.955,382.523,386.543,388.185,391.59,395.67,399.653,401.243,403.56,405.203,409.343,412.748,415.065,416.633,420.27,424.29,426.608,429.322,430.627,432.27,434.857,436.5,440.775,442.365,443.932,447.952,449.332,453.082,454.65,456.78,460.77,462.359,464.002,467.662,471.322,472.627,476.287,479.947,483.607,487.357,491.017,494.677" svgx:width="0.5,0.64,0.58,0.22,0.45,0.53,0.54,0.45,0.49,0.54,0.31,0.29,0.45,0.31,0.21,0.53,0.54,0.37,0.22,0.21,0.54,0.22,0.45,0.54,0.53,0.21,0.31,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.17,0.22,0.34,0.22,0.57,0.21,0.21,0.54,0.22,0.51,0.21,0.29,0.53,0.21,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">RNA concentrations in adult patients. J Clin Virol 31:304–309</text>
   <text y="147.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,324.113,326.325,329.73,333.87,335.438,336.705,340.448,346.283,347.588,349.23,355.125,358.53,362.55,366.63,370.62,374.603,376.815,380.22,384.24,385.508,388.673,389.978,391.62,396.008,397.598,399.833,404.558,407.963,414.105,417.743,421.38,425.46,427.103,429.81,431.115,432.758,436.238,437.805,441.825,445.905,447.473,449.115,453.503,457.89,459.195,460.838,465.225,466.815,472.958,476.595,479.932,483.952,485.542,488.947,492.577,494.219,498.899,503.287,504.592,506.234,510.959,514.942,517.739,520.537,524.174,525.742,529.762" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.58,0.29,0.45,0.55,0.21,0.22,0.5,0.78,0.17,0.22,0.78,0.45,0.54,0.54,0.53,0.53,0.29,0.45,0.54,0.22,0.5,0.17,0.22,0.58,0.21,0.3,0.63,0.45,0.82,0.49,0.49,0.54,0.22,0.46,0.17,0.22,0.46,0.21,0.54,0.54,0.21,0.22,0.58,0.58,0.17,0.22,0.58,0.21,0.82,0.49,0.42,0.54,0.21,0.45,0.48,0.22,0.62,0.58,0.17,0.22,0.63,0.53,0.37,0.37,0.49,0.21,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 29. Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein </text>
   <text y="156.638" x="319.725,325.455,329.843,331.148,332.79,335.408,339.398,342.195,345.833,347.475,349.95,351.255,352.897,356.505,358.072,362.092,364.365,368.355,369.997,373.785,375.09,376.732,381.12,382.71,385.056,390.089,396.231,399.636,401.901,403.469,405.111,409.499,410.804,412.446,416.3,420.32,423.725,425.938,429.343,433.483,436.888,438.53,442.918,444.223,445.865,450.253,451.843,457.985,461.975,464.293,467.698,469.265,471.53,473.098,474.74,479.128,480.433,482.075,486.463,488.053,489.695,493.55,497.57,500.975,503.292,504.86,509.0,510.642,514.542,515.847" svgx:width="0.78,0.58,0.17,0.22,0.34,0.53,0.37,0.49,0.22,0.34,0.17,0.22,0.5,0.21,0.54,0.31,0.53,0.22,0.5,0.17,0.22,0.58,0.21,0.3,0.67,0.82,0.45,0.29,0.21,0.22,0.58,0.17,0.22,0.5,0.54,0.45,0.29,0.45,0.55,0.45,0.22,0.58,0.17,0.22,0.58,0.21,0.82,0.53,0.31,0.45,0.21,0.29,0.21,0.22,0.58,0.17,0.22,0.58,0.21,0.22,0.5,0.54,0.45,0.31,0.21,0.55,0.22,0.5,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">MA, Jose J, Pinto R, Al-Omari A, Kharaba A, Almotairi A, Al Khatib K, </text>
   <text y="165.638" x="319.725,324.113,325.703,327.915,331.32,335.4,339.48,342.885,346.965,348.533,350.175,353.88,355.185,356.828,360.308,364.328,367.733,369.323,373.343,377.333,381.315,385.455,387.098,390.578,391.883,393.525,397.913,402.053,406.133,410.115,411.705,417.848,421.838,427.98,431.618,435.638,437.28,441.668,442.973,444.615,449.648,453.63,456.428,460.448,466.59,469.995,474.06,475.703,477.285,478.59,480.233,486.128,489.533,493.613,496.913,498.555,502.943,504.248,505.89,509.407,513.397,514.987,518.392,519.959,526.102,529.507,533.527" svgx:width="0.58,0.21,0.29,0.45,0.54,0.54,0.45,0.54,0.21,0.22,0.5,0.17,0.22,0.46,0.54,0.45,0.21,0.54,0.53,0.53,0.55,0.22,0.46,0.17,0.22,0.58,0.55,0.54,0.53,0.21,0.82,0.53,0.82,0.49,0.54,0.22,0.58,0.17,0.22,0.67,0.53,0.37,0.54,0.82,0.45,0.54,0.22,0.21,0.17,0.22,0.78,0.45,0.54,0.44,0.22,0.58,0.17,0.22,0.46,0.53,0.21,0.45,0.21,0.82,0.45,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Alraddadi B, Shalhoub S, Abdulmomen A, Qushmaq I, Mady A, Solaiman </text>
   <text y="174.638" x="319.725,324.533,325.838,327.48,331.868,333.458,335.693,340.08,341.648,343.965,347.985,351.39,355.41,357.053,361.395,367.23,368.535,370.178,374.565,376.155,378.39,382.282,385.687,389.767,393.847,397.252,401.332,402.9,404.542,408.33,409.635,411.277,415.169,418.574,422.654,426.059,430.199,431.841,436.229,437.534,439.176,442.964,446.369,447.959,451.295,455.24,458.54,460.183,464.908,469.633,470.938,472.58,476.968,478.558,480.2,484.925,488.33,490.738,493.055,497.0,500.3,501.943,506.33,507.635,509.278,514.175,517.813,521.45,525.59" svgx:width="0.67,0.17,0.22,0.58,0.21,0.3,0.58,0.21,0.31,0.54,0.45,0.54,0.22,0.58,0.78,0.17,0.22,0.58,0.21,0.3,0.5,0.45,0.54,0.54,0.45,0.54,0.21,0.22,0.5,0.17,0.22,0.5,0.45,0.54,0.45,0.55,0.22,0.58,0.17,0.22,0.5,0.45,0.21,0.42,0.54,0.44,0.22,0.63,0.63,0.17,0.22,0.58,0.21,0.22,0.63,0.45,0.29,0.31,0.54,0.44,0.22,0.58,0.17,0.22,0.65,0.49,0.49,0.55,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">O, Al-Aithan AM, Al-Raddadi R, Ragab A, Balkhy HH, Al Harthy A, Deeb </text>
   <text y="183.638" x="319.725,324.068,329.903,331.208,332.85,337.238,338.828,340.47,346.335,350.318,352.635,356.04,357.608,359.873,361.44,363.083,367.808,369.113,370.755,375.143,376.733,378.968,383.82,387.18,392.543,396.533,400.523,404.603,406.245,410.633,411.938,413.58,419.475,423.113,425.325,428.123,432.113,436.133,437.775,441.135,442.44,444.083,448.808,452.168,455.415,459.495,463.133,467.153,468.795,472.26,476.94,478.245,479.888,483.097,487.05,492.465,494.055,497.693,499.905,501.548,505.335,509.723,511.028,512.67,516.15,519.555,523.538,527.618,529.185" svgx:width="0.58,0.78,0.17,0.22,0.58,0.21,0.22,0.78,0.53,0.31,0.45,0.21,0.29,0.21,0.22,0.63,0.17,0.22,0.58,0.21,0.3,0.65,0.45,0.72,0.53,0.53,0.54,0.22,0.58,0.17,0.22,0.78,0.49,0.29,0.37,0.53,0.54,0.22,0.45,0.17,0.22,0.63,0.45,0.44,0.54,0.49,0.54,0.22,0.46,0.62,0.17,0.22,0.46,0.53,0.72,0.21,0.49,0.29,0.22,0.5,0.58,0.17,0.22,0.46,0.45,0.53,0.54,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">AM, Al Mutairi H, Al-Dawood A, Merson L, Hayden FG, Fowler RA, Saudi </text>
   <text y="192.638" x="319.725,324.0,326.265,327.833,330.15,331.718,335.063,338.468,340.058,341.7,345.945,349.35,351.48,355.117,356.445,359.632,361.897,363.465,366.87,368.46,370.102,374.782,376.425,378.412,382.072,385.732,389.392,393.052,395.04,396.682,400.912,404.902,407.31,409.627,411.195,414.54,418.53,421.327,423.599,427.237,429.367,433.357,434.924,439.004,440.647,442.964,446.984,450.622,452.834,456.239,460.342,463.642,465.284,467.137,471.127,473.339,474.982,478.327,480.591,482.159,484.476,486.044,489.389,492.794,494.384,495.974,499.274,500.916,502.484,504.074,505.664,507.306,511.446,514.851,517.169,518.736,522.374,526.394,528.711,531.509" svgx:width="0.57,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22,0.57,0.45,0.29,0.49,0.22,0.47,0.29,0.21,0.45,0.21,0.22,0.62,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.57,0.53,0.29,0.31,0.21,0.45,0.53,0.37,0.31,0.49,0.29,0.53,0.21,0.54,0.22,0.31,0.54,0.49,0.29,0.45,0.55,0.44,0.22,0.26,0.53,0.29,0.22,0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.21,0.21,0.21,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Critical Care Trial G (2018) Corticosteroid therapy for critically ill patients </text>
   <text y="201.638" x="319.725,325.14,326.708,329.025,333.045,334.688,340.83,342.398,346.478,350.558,352.148,355.785,357.428,361.065,364.47,367.268,369.585,371.228,373.358,376.995,379.793,383.933,385.5,387.713,391.118,393.39,397.38,399.818,403.118,404.76,407.558,410.858,414.878,418.958,421.088,425.078,431.22,434.783,436.088,437.73,442.118,448.26,449.903,452.49,454.133,457.957,461.594,464.392,468.532,470.099,472.312,473.954,478.229,480.494,482.061,484.379,486.021,490.266,493.671,495.801,499.439,501.081,506.976,510.614,514.694" svgx:width="0.72,0.21,0.31,0.54,0.22,0.82,0.21,0.54,0.54,0.21,0.49,0.22,0.49,0.45,0.37,0.31,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.37,0.44,0.54,0.54,0.29,0.53,0.82,0.49,0.17,0.22,0.58,0.82,0.22,0.34,0.22,0.5,0.49,0.37,0.55,0.21,0.29,0.22,0.57,0.29,0.21,0.31,0.22,0.57,0.45,0.29,0.49,0.22,0.78,0.49,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">with middle east respiratory syndrome. Am J Respir Crit Care Med </text>
   <text y="210.638" x="319.725,323.385,327.045,330.705,332.01,335.67,339.33,342.99,346.74,350.4,354.06" svgx:width="0.49,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">197:757–767</text>
   <text y="219.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,322.958,326.595,330.233,331.875,335.355,341.19,342.495,344.138,348.413,352.433,356.07,360.053,364.073,368.153,369.795,374.07,377.235,378.54,380.183,385.08,386.647,389.992,394.012,398.002,399.592,401.182,403.98,405.622,408.21,414.044,415.349,416.992,421.717,425.699,427.267,428.909,432.644,435.374,436.679,438.322,441.554,445.192,449.174,453.194,457.274,458.917,463.192,466.357,467.662,469.304,473.999,475.567,479.707,481.919,485.324,488.122,491.759,494.167,496.484,499.709,503.691,505.281,506.924,512.759,514.064,515.391,518.841,520.409,524.549,528.539,532.176" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.45,0.49,0.49,0.22,0.46,0.78,0.17,0.22,0.57,0.54,0.49,0.53,0.54,0.54,0.22,0.57,0.5,0.17,0.22,0.64,0.21,0.45,0.54,0.53,0.21,0.21,0.37,0.22,0.34,0.78,0.17,0.22,0.63,0.53,0.21,0.22,0.5,0.5,0.17,0.22,0.45,0.49,0.53,0.54,0.54,0.22,0.57,0.5,0.17,0.22,0.63,0.21,0.55,0.29,0.45,0.37,0.49,0.29,0.31,0.42,0.53,0.21,0.22,0.78,0.17,0.22,0.47,0.21,0.55,0.53,0.49,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 30. Lee SM, Cheung CY, Nicholls JM, Hui KP, Leung CY, Uiprasertkul M, Tipoe </text>
   <text y="228.638" x="319.725,324.405,327.765,329.07,330.713,334.073,337.478,341.46,342.728,346.5,349.86,351.165,352.808,356.378,360.368,364.358,368.378,370.02,373.38,376.74,378.045,379.688,381.383,385.523,387.165,391.95,395.115,396.42,398.063,402.743,406.725,410.13,414.15,415.418,418.582,419.887,421.529,425.099,428.736,430.304,432.569,434.136,436.934,438.576,441.164,444.644,446.286,448.274,451.934,455.594,459.254,462.914,464.901,466.544,471.374,474.674,478.814,482.451,484.715,486.283,490.303,494.383,498.365,501.793,504.11,505.678,509.668,513.688,515.33,519.32,521.285" svgx:width="0.62,0.45,0.17,0.22,0.45,0.45,0.53,0.22,0.5,0.45,0.17,0.22,0.5,0.53,0.53,0.54,0.22,0.45,0.45,0.17,0.22,0.21,0.55,0.22,0.64,0.5,0.17,0.22,0.62,0.53,0.45,0.54,0.22,0.5,0.17,0.22,0.5,0.49,0.21,0.29,0.21,0.37,0.22,0.34,0.46,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.63,0.44,0.55,0.49,0.29,0.21,0.54,0.54,0.53,0.45,0.31,0.21,0.53,0.54,0.22,0.53,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">GL, Lau YL, Poon LL, Ip NY, Guan Y, Peiris JS (2008) Hyperinduction of </text>
   <text y="237.638" x="319.725,323.213,326.46,329.805,331.395,335.385,339.315,342.623,345.87,349.95,353.588,357.608,361.013,363.81,367.643,369.878,373.538,375.773,381.915,385.553,389.633,391.2,394.605,396.878,400.515,404.595,406.238,410.378,412.509,416.499,418.066,422.086,425.716,429.121,435.264,441.406,444.811,447.083,451.073,453.511,456.811,458.453,461.798,465.203,468.001,471.346,474.751,478.831,482.468,483.773,485.416,488.821,490.463,496.606,500.243,503.588,507.608,511.013,515.033,516.601,519.398,525.541" svgx:width="0.45,0.44,0.45,0.21,0.53,0.53,0.43,0.44,0.54,0.49,0.54,0.45,0.37,0.49,0.3,0.49,0.3,0.82,0.49,0.54,0.21,0.45,0.31,0.49,0.54,0.22,0.55,0.29,0.53,0.21,0.54,0.48,0.45,0.82,0.82,0.45,0.31,0.53,0.29,0.44,0.22,0.45,0.45,0.37,0.45,0.45,0.54,0.49,0.17,0.22,0.45,0.22,0.82,0.49,0.45,0.54,0.45,0.54,0.21,0.37,0.82,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">cyclooxygenase-2-mediated proinflammatory cascade: a mechanism </text>
   <text y="246.638" x="319.725,321.578,325.568,327.78,329.423,331.74,335.76,339.398,341.04,345.18,348.585,350.903,354.923,358.913,362.993,366.63,370.65,374.288,377.085,378.653,381.45,383.093,387.083,389.048,390.69,394.05,397.44,399.008,402.413,406.433,408.075,409.643,413.663,417.293,421.275,424.913,428.933,431.955,435.36,437.003,441.728,445.388,450.173,453.833,455.475,457.043,461.063,462.915,466.553,469.98,472.297,473.865,477.855,481.875,483.18,484.822,487.41,489.052,490.747,494.767,496.619,500.257,503.684,506.001,507.644,512.496,514.064,516.861" svgx:width="0.26,0.53,0.29,0.22,0.31,0.54,0.49,0.22,0.55,0.45,0.31,0.54,0.53,0.54,0.49,0.54,0.49,0.37,0.21,0.37,0.22,0.53,0.26,0.22,0.45,0.45,0.21,0.45,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.63,0.49,0.64,0.49,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.17,0.22,0.34,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">for the pathogenesis of avian influenza H5N1 infection. J Infect Dis </text>
   <text y="255.638" x="319.725,323.385,327.045,330.705,332.01,335.67,339.33,342.99,346.74,350.4,354.06" svgx:width="0.49,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">198:525–535</text>
   <text y="264.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,324.45,328.433,332.453,336.533,338.175,339.758,342.465,343.77,345.15,351.09,354.495,358.515,362.595,363.922,366.915,370.905,372.547,376.282,380.182,381.487,383.129,387.404,391.424,394.829,398.849,400.492,402.967,404.272,405.914,410.189,414.209,417.614,421.634,423.277,427.012,431.737,433.042,434.309,437.767,441.749,445.387,449.407,451.049,454.784,457.949,459.254,460.897,464.392,468.547,472.822,478.657,480.239,485.092,486.734,490.394,494.054,497.714,501.374,502.679,504.322,509.354,513.014,516.674,520.334,523.994" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.63,0.53,0.54,0.54,0.22,0.21,0.46,0.17,0.22,0.82,0.45,0.54,0.54,0.22,0.47,0.53,0.22,0.5,0.5,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.34,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.63,0.17,0.22,0.5,0.53,0.49,0.54,0.22,0.5,0.5,0.17,0.22,0.47,0.57,0.57,0.78,0.21,0.65,0.22,0.49,0.49,0.49,0.49,0.17,0.22,0.67,0.49,0.49,0.49,0.49,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 31. Hung IF, Wang To KK, Chan J, Chan KH, Yuen KY. ECCMID 2019. O0815 </text>
   <text y="273.638" x="319.725,322.913,325.043,328.68,332.085,334.403,340.545,344.183,348.203,350.52,352.163,356.153,358.118,359.76,362.558,366.225,369.563,373.2,375.33,378.968,380.61,382.178,386.198,389.828,393.81,397.448,401.468,404.49,407.895,409.538,413.925,415.568,417.135,421.155,423.008,426.645,430.073,432.39,433.958,437.948,441.968,443.61,449.025,450.593,452.91,456.93,458.573,461.918,465.555,467.145,470.783,474.128,478.058,481.275,482.843,486.848,488.153" svgx:width="0.47,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.58,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.22,0.72,0.21,0.31,0.54,0.22,0.45,0.49,0.21,0.49,0.45,0.53,0.43,0.21,0.55,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Treatment of severe influenza A infection with celecoxib. </text>
   <text y="273.638" x="489.795,493.815,496.133,498.45,502.59,505.388,505.388,506.693,509.325,511.958,517.433,522.908,528.068" svgx:width="0.54,0.31,0.31,0.55,0.37,0.22,0.17,0.35,0.35,0.72,0.72,0.72,0.17" style="fill:rgb(0,0,255);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">https ://www.</text>
   <text y="282.638" x="319.725,323.363,326.16,329.505,335.648,337.215,337.215,341.212,342.517,346.507,348.652" svgx:width="0.49,0.37,0.45,0.82,0.21,0.22,0.54,0.17,0.53,0.29,0.54" style="fill:rgb(0,0,255);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">escmi d.org</text>
   <text y="282.638" x="352.628,353.933,355.575,359.888,363.233,366.578,370.215,373.013,375.81,379.448,383.528,385.17,388.83,392.49,394.133,397.65,401.288,405.428,407.07,410.73,414.39,418.05" svgx:width="0.17,0.22,0.58,0.45,0.45,0.49,0.37,0.37,0.49,0.54,0.22,0.49,0.49,0.22,0.46,0.49,0.55,0.22,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">. Accessed 14 Sep 2019</text>
   <text y="291.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,322.313,323.88,327.285,328.928,333.023,334.328,335.97,339.33,340.898,344.88,346.523,350.228,351.533,353.175,356.963,360.368,364.358,366.0,369.36,370.665,372.308,375.51,378.9,380.543,385.35,386.655,388.298,391.658,393.225,394.868,397.574,398.879,400.522,403.882,405.449,407.092,411.817,413.122,414.764,419.152,423.172,424.439,427.604,428.909,430.552,434.594,438.614,442.019,446.039,450.119,451.762,455.857,457.162,458.804,463.049,466.454,470.444,472.087,475.792,477.097,478.477,484.417,487.822,491.842,495.922,497.564,501.839,503.482,505.469,509.129,512.789,516.449,520.109,522.097" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.34,0.21,0.45,0.22,0.55,0.17,0.22,0.45,0.21,0.53,0.22,0.5,0.17,0.22,0.5,0.45,0.53,0.22,0.45,0.17,0.22,0.45,0.45,0.22,0.67,0.17,0.22,0.45,0.21,0.22,0.46,0.17,0.22,0.45,0.21,0.22,0.63,0.17,0.22,0.58,0.54,0.22,0.5,0.17,0.22,0.54,0.54,0.45,0.54,0.54,0.22,0.55,0.17,0.22,0.57,0.45,0.53,0.22,0.5,0.17,0.22,0.82,0.45,0.54,0.54,0.22,0.57,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 32. Jia X, Liu B, Bao L, Lv Q, Li F, Li H, An Y, Zhang X, Cao B, Wang C (2018) </text>
   <text y="300.638" x="319.725,324.623,328.26,329.85,333.21,336.458,340.095,344.175,345.818,349.808,352.605,356.243,357.833,360.15,363.555,369.698,371.265,374.655,376.223,378.435,380.078,384.218,385.808,389.79,392.588,394.23,397.028,398.595,400.725,404.715,406.305,407.873,414.015,417.998,420.795,422.438,424.755,426.885,430.523,433.928,436.245,442.388,446.025,450.045,452.363,454.005,457.41,459.728,462.0,465.638,469.658,473.64,477.045,479.318,482.955,485.753,487.395,492.12,495.78,500.565,504.225,505.868,509.258,510.825,513.038,517.02,519.818" svgx:width="0.65,0.49,0.21,0.45,0.44,0.49,0.54,0.22,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.55,0.21,0.53,0.37,0.22,0.37,0.21,0.29,0.53,0.21,0.21,0.82,0.53,0.37,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.45,0.31,0.31,0.49,0.54,0.53,0.45,0.31,0.49,0.37,0.22,0.63,0.49,0.64,0.49,0.22,0.45,0.21,0.29,0.53,0.37,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-</text>
   <text y="309.638" x="319.725,321.293,325.313,329.393,333.375,336.72,340.358,344.438,346.08,348.878,352.545,355.883,359.52,361.65,365.288,366.93,368.52,372.503,376.523,380.603,382.245,383.813,387.833,389.438,393.42,395.858,399.158,400.8,404.145,408.135,410.4,412.53,416.168,417.758,421.163,423.435,427.073,431.153,432.795,438.21,439.778,442.095,446.115,447.758,449.888,453.525,457.665,459.795,463.433,466.23,469.028,472.665,476.745,478.388,483.173,486.533,490.32,494.085,497.745,499.388,500.955,504.975,508.605,512.01,518.153" svgx:width="0.21,0.54,0.54,0.53,0.45,0.49,0.54,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.21,0.53,0.54,0.54,0.22,0.21,0.54,0.21,0.53,0.29,0.44,0.22,0.45,0.53,0.29,0.29,0.49,0.21,0.45,0.31,0.49,0.54,0.22,0.72,0.21,0.31,0.54,0.22,0.29,0.49,0.55,0.29,0.49,0.37,0.37,0.49,0.54,0.22,0.64,0.45,0.5,0.5,0.49,0.22,0.21,0.54,0.48,0.45,0.82,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">induced severe lung injury correlated with repressed NLRP3 inflam-</text>
   <text y="318.638" x="319.725,325.868,329.273,332.07,336.06,342.203,345.84,347.483,350.888,354.315,356.633,358.2,361.59,364.995,367.313,368.88,372.87,376.89,378.533,381.938,385.958,390.038,391.68,393.248,397.268,400.898,404.303,410.445,416.588,419.993,422.265,426.255,428.693,431.993,433.635,436.98,440.618,442.208,443.798,445.44,447.008,451.028,454.658,456.248,458.565,460.778,464.183,466.5,468.068,472.058,476.078,477.383,479.025,482.79,486.023,490.013,493.493,495.135,498.675,502.08,504.398,508.418,512.408,516.488" svgx:width="0.82,0.45,0.37,0.53,0.82,0.49,0.22,0.45,0.45,0.31,0.21,0.45,0.45,0.31,0.21,0.53,0.54,0.22,0.45,0.54,0.54,0.22,0.21,0.54,0.48,0.45,0.82,0.82,0.45,0.31,0.53,0.29,0.44,0.22,0.45,0.49,0.21,0.21,0.22,0.21,0.54,0.48,0.21,0.31,0.29,0.45,0.31,0.21,0.53,0.54,0.17,0.22,0.5,0.45,0.53,0.46,0.22,0.5,0.45,0.31,0.54,0.53,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">masome activation and inflammatory cell infiltration. PLoS Pathog </text>
   <text y="327.638" x="319.725,323.385,327.045,328.35,331.988,335.648,339.308,342.968,346.628,350.288,353.948" svgx:width="0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">14:e1007428</text>
   <text y="336.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,324.45,328.433,331.838,335.858,339.938,341.58,346.14,349.29,350.595,352.237,356.962,360.945,364.965,369.045,370.687,374.962,378.127,379.432,381.075,385.35,389.37,393.007,397.027,398.354,401.647,405.922,407.227,408.869,412.229,413.797,417.817,419.459,423.734,426.899,428.204,429.847,433.207,434.774,438.794,440.062,443.617,447.892,449.197,450.839,455.114,459.134,462.539,466.559,470.639,472.282,476.557,480.037,481.342,482.984,487.709,491.347,492.614,496.169,500.444,501.749,503.392,508.117,512.099,515.504,519.524,523.604,524.872,528.644,532.004,533.309" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.63,0.53,0.45,0.54,0.54,0.22,0.57,0.47,0.17,0.22,0.63,0.53,0.54,0.54,0.22,0.57,0.5,0.17,0.22,0.57,0.54,0.49,0.54,0.22,0.47,0.57,0.17,0.22,0.45,0.21,0.54,0.22,0.57,0.5,0.17,0.22,0.45,0.21,0.54,0.22,0.5,0.57,0.17,0.22,0.57,0.54,0.45,0.54,0.54,0.22,0.57,0.46,0.17,0.22,0.63,0.49,0.22,0.5,0.57,0.17,0.22,0.63,0.53,0.45,0.54,0.54,0.22,0.5,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 33. Huang CT, Hung CY, Chen TC, Lin CY, Lin YC, Chang CS, He YC, Huang YL, </text>
   <text y="345.638" x="319.725,324.578,328.56,330.878,333.195,336.6,338.243,342.63,344.273,346.26,349.92,353.58,357.24,360.9,362.888,364.53,368.423,371.828,375.968,379.373,385.44,388.688,392.033,393.6,397.62,399.263,402.668,406.748,408.353,412.335,415.725,419.13,423.15,425.468,427.11,430.515,434.535,438.615,440.258,443.895,447.113,450.518,453.863,457.5,459.773,463.913,467.318,469.635,471.203,475.193,479.213,480.855,484.845,486.81,488.453,491.25,494.918,498.255,501.893,504.023,507.66,509.303,510.87,514.89,518.52,522.503,526.14,530.16,533.183,536.588" svgx:width="0.65,0.53,0.31,0.31,0.45,0.22,0.58,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.5,0.45,0.55,0.45,0.82,0.44,0.45,0.21,0.54,0.22,0.45,0.54,0.21,0.53,0.45,0.45,0.54,0.31,0.22,0.45,0.54,0.54,0.22,0.49,0.43,0.45,0.45,0.49,0.29,0.55,0.45,0.31,0.21,0.53,0.54,0.22,0.53,0.26,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Dutta A (2017) Rapamycin adjuvant and exacerbation of severe influenza </text>
   <text y="354.638" x="319.725,321.293,325.313,326.955,330.36,334.38,336.023,339.66,342.878,347.018,350.655,352.92,354.488,360.63,364.268,368.288,370.605,374.01,375.6,377.243,383.385,387.375,391.358,394.155,397.793,399.435,405.578,409.568,413.648,417.285,418.793,420.098,421.74,425.258,428.603,430.17,431.813,435.638,439.275,443.415,445.058,448.718,450.023,453.683,457.343,461.003" svgx:width="0.21,0.54,0.22,0.45,0.54,0.22,0.49,0.43,0.55,0.49,0.29,0.21,0.82,0.49,0.54,0.31,0.45,0.21,0.22,0.82,0.53,0.53,0.37,0.49,0.22,0.82,0.53,0.54,0.49,0.21,0.17,0.22,0.46,0.45,0.21,0.22,0.5,0.49,0.55,0.22,0.49,0.17,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">in an experimental mouse model. Sci Rep 7:4136</text>
   <text y="363.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,325.665,329.07,333.09,337.17,338.813,343.088,347.813,349.118,350.76,355.035,359.055,363.038,367.058,371.138,372.78,376.245,379.395,380.7,382.343,385.703,387.27,391.29,392.933,396.413,402.248,403.553,405.195,409.92,413.903,417.308,421.328,425.408,427.05,430.53,433.695,435.0,436.643,440.918,444.938,448.928,452.91,454.553,458.828,462.188,463.493,465.135,468.368,472.005,475.643,477.285,481.02,484.184,485.489,487.132,490.492,492.059,496.079,497.407,501.194,504.359,505.664,507.307,511.042,515.024,519.014,520.657,525.382,529.147" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.82,0.45,0.54,0.54,0.22,0.57,0.63,0.17,0.22,0.57,0.54,0.53,0.54,0.54,0.22,0.46,0.47,0.17,0.22,0.45,0.21,0.54,0.22,0.46,0.78,0.17,0.22,0.63,0.53,0.45,0.54,0.54,0.22,0.46,0.5,0.17,0.22,0.57,0.54,0.53,0.53,0.22,0.57,0.45,0.17,0.22,0.45,0.49,0.49,0.22,0.5,0.5,0.17,0.22,0.45,0.21,0.54,0.22,0.47,0.5,0.17,0.22,0.5,0.53,0.53,0.22,0.63,0.5,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 34. Wang CH, Chung FT, Lin SM, Huang SY, Chou CL, Lee KY, Lin TY, Kuo HP </text>
   <text y="372.638" x="319.725,321.713,325.373,329.033,332.693,336.353,338.34,339.983,344.295,348.375,349.98,353.962,357.352,360.757,364.777,367.095,368.737,371.055,373.185,376.822,380.227,382.545,388.687,392.325,396.345,398.662,400.305,405.72,407.287,409.605,413.625,415.267,418.672,420.315,426.457,429.862,436.005,442.147,445.552,447.142,448.71,452.115,456.135,457.777,460.095,463.5,465.645,469.725,473.362,475.68,477.322,481.312,483.277,484.92,487.132,490.537,494.677,498.082,504.15,507.397,510.742,512.31,516.33,517.972,519.54,523.56,527.58,529.147,533.287,534.855" svgx:width="0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.58,0.54,0.21,0.53,0.45,0.45,0.54,0.31,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.72,0.21,0.31,0.54,0.22,0.45,0.22,0.82,0.45,0.82,0.82,0.45,0.21,0.21,0.45,0.54,0.22,0.31,0.45,0.29,0.54,0.49,0.31,0.22,0.53,0.26,0.22,0.29,0.45,0.55,0.45,0.82,0.44,0.45,0.21,0.54,0.22,0.21,0.54,0.54,0.21,0.55,0.21,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">(2014) Adjuvant treatment with a mammalian target of rapamycin inhibi-</text>
   <text y="381.638" x="319.725,321.998,325.988,327.863,329.168,330.81,333.608,335.175,337.305,341.295,342.885,344.453,350.595,354.578,357.293,358.598,360.24,363.645,367.665,371.745,373.388,376.185,378.458,382.095,384.225,388.215,389.783,393.863,396.66,398.303,399.87,406.013,410.153,412.283,416.235,419.573,423.21,426.008,427.65,431.64,435.623,437.895,441.24,445.23,451.373,455.01,457.808,459.45,461.018,465.038,466.68,470.82,474.225,476.543,478.11,481.748,485.768,488.085,490.883,492.525,497.94,499.508,501.825,505.845,507.488,510.285,513.953,517.29,520.928,523.058,526.695" svgx:width="0.31,0.53,0.29,0.17,0.22,0.37,0.21,0.29,0.53,0.21,0.21,0.82,0.53,0.37,0.17,0.22,0.45,0.54,0.54,0.22,0.37,0.31,0.49,0.29,0.53,0.21,0.54,0.37,0.22,0.21,0.82,0.55,0.29,0.53,0.45,0.49,0.37,0.22,0.53,0.53,0.31,0.45,0.53,0.82,0.49,0.37,0.22,0.21,0.54,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">tor, sirolimus, and steroids improves outcomes in patients with severe </text>
   <text y="390.638" x="319.725,324.45,328.11,332.895,336.555,338.198,342.338,346.358,349.995,353.978,360.12,364.11,368.13,369.698,373.103,374.745,378.15,382.17,386.25,387.893,391.298,394.643,398.625,400.898,404.535,406.178,408.308,411.945,414.743,418.883,420.45,422.663,426.068,428.34,432.33,434.767,438.067,439.71,441.675,445.08,446.647,448.237,452.22,454.35,457.912,459.217,460.86,465.135,467.399,468.966,471.284,472.926,477.171,480.576,482.706,486.343,487.986,493.881,497.518,501.598,503.241,506.901,510.561,511.866,515.526,519.185,522.845,526.595,530.255,533.915" svgx:width="0.63,0.49,0.64,0.49,0.22,0.55,0.54,0.49,0.53,0.82,0.53,0.54,0.21,0.45,0.22,0.45,0.54,0.54,0.22,0.45,0.45,0.53,0.31,0.49,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.26,0.45,0.21,0.21,0.53,0.29,0.49,0.17,0.22,0.57,0.29,0.21,0.31,0.22,0.57,0.45,0.29,0.49,0.22,0.78,0.49,0.54,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">H1N1 pneumonia and acute respiratory failure. Crit Care Med 42:313–321</text>
   <text y="399.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,325.62,328.965,333.278,337.26,338.85,342.517,345.817,347.46,352.312,355.02,356.325,357.967,361.327,364.732,368.685,372.352,375.652,377.295,379.882,384.562,385.867,387.51,392.625,393.93,397.852,401.257,405.277,408.915,410.557,414.832,420.667,421.972,423.614,427.184,430.822,433.094,436.432,437.999,442.019,444.817,446.459,451.139,455.766,457.071,458.714,464.579,468.561,470.151,471.741,475.146,479.166,480.809,484.514,485.819,487.146,490.334,492.599,494.166,498.186,502.266,505.904,508.116,509.444,512.646,515.121,516.426,518.069,520.686,524.676,528.696,532.716" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.78,0.45,0.58,0.53,0.21,0.49,0.44,0.22,0.65,0.46,0.17,0.22,0.45,0.45,0.54,0.49,0.44,0.22,0.34,0.62,0.17,0.22,0.67,0.17,0.5,0.45,0.54,0.49,0.22,0.57,0.78,0.17,0.22,0.5,0.49,0.29,0.42,0.21,0.54,0.37,0.22,0.62,0.65,0.17,0.22,0.78,0.53,0.21,0.21,0.45,0.54,0.22,0.5,0.17,0.22,0.47,0.29,0.21,0.54,0.54,0.49,0.29,0.22,0.47,0.34,0.17,0.22,0.34,0.53,0.54,0.54,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 35. McAuley DF, Laffey JG, O’Kane CM, Perkins GD, Mullan B, Trinder TJ, John-</text>
   <text y="408.638" x="319.725,322.523,324.795,328.785,332.805,334.448,337.178,338.483,340.125,344.85,348.84,352.98,356.318,357.885,361.905,364.703,366.345,369.368,373.755,375.06,376.703,379.32,383.31,387.33,391.35,394.147,396.419,400.409,404.429,406.072,410.624,413.099,414.404,416.047,421.942,425.287,430.184,434.136,439.499,443.136,444.726,446.316,447.959,452.234,453.539,455.181,461.076,464.421,469.206,472.611,474.201,475.791,479.091,480.734,485.009,486.314,487.956,489.651,493.596,496.934,500.571,503.369,505.686,507.254,511.334,514.739,517.011,521.001,523.214,526.011" svgx:width="0.37,0.31,0.53,0.54,0.22,0.5,0.17,0.22,0.63,0.53,0.55,0.42,0.21,0.54,0.37,0.22,0.5,0.58,0.17,0.22,0.34,0.53,0.54,0.54,0.37,0.31,0.53,0.54,0.22,0.58,0.34,0.17,0.22,0.78,0.45,0.65,0.53,0.72,0.49,0.21,0.21,0.22,0.57,0.17,0.22,0.78,0.45,0.64,0.45,0.21,0.21,0.44,0.22,0.57,0.17,0.22,0.21,0.54,0.45,0.49,0.37,0.31,0.21,0.54,0.45,0.31,0.53,0.29,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ston P, Hopkins PA, Johnston AJ, McDowell C, McNally C, Investigators </text>
   <text y="417.638" x="319.725,324.45,326.685,327.99,329.633,331.328,333.593,335.16,337.958,341.978,343.62,347.895,350.16,351.728,354.045,355.613,358.958,362.363,363.953,365.595,369.84,373.245,375.375,379.013,380.34,383.528,385.792,387.359,390.764,392.354,395.152,396.794,401.474,403.117,405.104,408.764,412.424,416.084,419.744,421.732,423.374,426.854,428.422,434.489,437.879,441.284,444.082,446.399,449.804,452.122,453.689,457.709,459.352,460.919,464.939,466.582,468.899,472.919,476.557,478.199,481.604,484.949,488.932,491.204,494.842,496.484,498.614,502.252,505.049,509.189,510.757,512.969,516.374,518.647,522.637,525.074,528.374" svgx:width="0.63,0.3,0.17,0.22,0.21,0.29,0.21,0.37,0.54,0.22,0.57,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22,0.57,0.45,0.29,0.49,0.22,0.47,0.29,0.21,0.45,0.21,0.37,0.22,0.62,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.46,0.21,0.82,0.45,0.45,0.37,0.31,0.45,0.31,0.21,0.54,0.22,0.21,0.54,0.22,0.31,0.54,0.49,0.22,0.45,0.45,0.53,0.31,0.49,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">H-, Irish Critical Care Trials G (2014) Simvastatin in the acute respiratory </text>
   <text y="426.638" x="319.725,323.805,325.373,328.17,330.488,332.618,336.255,339.053,341.85,343.493,346.29,349.59,353.61,357.69,359.82,363.81,369.953,373.515,374.82,376.463,381.248,382.89,386.385,390.405,394.485,396.075,397.718,400.305,401.948,407.843,411.48,415.56,417.203,420.863,424.523,428.183,429.488,433.148,436.808,440.468,444.128,447.878,451.538,455.198,458.858" svgx:width="0.54,0.21,0.37,0.31,0.29,0.49,0.37,0.37,0.22,0.37,0.44,0.54,0.54,0.29,0.53,0.82,0.49,0.17,0.22,0.64,0.22,0.47,0.54,0.54,0.21,0.22,0.34,0.22,0.78,0.49,0.54,0.22,0.49,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">distress syndrome. N Engl J Med 371:1695–1703</text>
   <text y="435.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,323.97,327.375,328.965,330.818,334.455,338.093,339.735,344.01,347.49,348.795,350.438,355.335,358.973,360.563,364.545,367.89,371.235,375.255,376.823,378.465,382.2,385.56,386.865,388.508,391.988,393.555,397.575,401.595,405.0,406.643,409.373,410.678,412.32,418.215,421.62,423.938,426.255,430.275,433.635,436.935,438.578,444.308,448.695,450.0,451.643,456.368,459.773,463.118,466.373,470.01,472.328,474.645,476.288,478.762,480.067,481.709,485.189,489.209,492.614,496.634,500.001,503.406,505.559,507.794,512.519,515.924,518.189,519.756" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.57,0.45,0.21,0.26,0.49,0.49,0.22,0.57,0.46,0.17,0.22,0.65,0.49,0.21,0.53,0.45,0.45,0.54,0.21,0.22,0.5,0.45,0.17,0.22,0.46,0.21,0.54,0.54,0.45,0.22,0.5,0.17,0.22,0.78,0.45,0.31,0.31,0.54,0.45,0.44,0.22,0.78,0.58,0.17,0.22,0.63,0.45,0.45,0.42,0.49,0.31,0.31,0.22,0.34,0.17,0.22,0.46,0.54,0.45,0.54,0.42,0.45,0.29,0.3,0.63,0.45,0.29,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 36. Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari </text>
   <text y="444.638" x="319.725,325.56,326.865,328.508,334.403,337.748,342.645,346.598,351.96,355.598,357.188,358.778,360.42,364.695,366.0,367.643,371.003,374.408,378.36,382.028,385.328,386.97,389.558,394.238,395.543,397.185,402.3,403.605,407.528,410.933,414.953,418.59,420.233,424.508,430.343,431.648,433.29,439.185,442.53,446.843,450.825,452.415,456.083,459.383,461.025,465.878,468.585,469.89,471.533,473.228,475.493,477.06,479.858,483.878,485.52,489.795,492.059,493.627,495.944,497.512,500.857,504.262,505.852,507.494,511.739,515.144,517.274,520.912" svgx:width="0.78,0.17,0.22,0.78,0.45,0.65,0.53,0.72,0.49,0.21,0.21,0.22,0.57,0.17,0.22,0.45,0.45,0.54,0.49,0.44,0.22,0.34,0.62,0.17,0.22,0.67,0.17,0.5,0.45,0.54,0.49,0.22,0.57,0.78,0.17,0.22,0.78,0.45,0.58,0.53,0.21,0.49,0.44,0.22,0.65,0.46,0.17,0.22,0.21,0.29,0.21,0.37,0.54,0.22,0.57,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22,0.57,0.45,0.29,0.49,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">M, McDowell C, Laffey JG, O’Kane CM, McAuley DF, Irish Critical Care </text>
   <text y="453.638" x="319.725,322.913,325.178,326.745,330.15,331.74,334.538,336.18,340.86,342.503,344.49,348.15,351.81,355.47,359.13,361.118,362.76,367.073,370.418,374.4,376.673,380.31,381.953,384.083,387.72,390.518,394.658,396.225,398.438,401.843,404.115,408.105,410.543,413.843,415.485,419.565,421.133,423.93,426.248,428.378,432.015,434.813,437.61,439.253,442.05,445.35,449.37,453.45,455.58,459.57,465.713,469.35,470.993,473.79,477.773,481.913,486.053,490.073,493.71,497.73,501.72,504.119,507.419,511.559,515.197,517.994,519.637,523.042,527.062,531.142" svgx:width="0.47,0.29,0.21,0.45,0.21,0.37,0.22,0.62,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.58,0.45,0.53,0.31,0.49,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.54,0.21,0.37,0.31,0.29,0.49,0.37,0.37,0.22,0.37,0.44,0.54,0.54,0.29,0.53,0.82,0.49,0.22,0.37,0.53,0.55,0.55,0.54,0.49,0.54,0.53,0.31,0.44,0.55,0.49,0.37,0.22,0.45,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Trials G (2018) Acute respiratory distress syndrome subphenotypes and </text>
   <text y="462.638" x="319.725,323.805,325.373,329.325,332.963,335.093,338.73,342.75,345.068,346.635,350.04,351.63,353.273,355.403,359.04,361.838,365.978,369.968,373.988,376.785,380.423,382.065,384.337,388.327,389.97,392.767,394.335,400.402,403.792,407.197,409.995,412.312,415.717,418.035,419.602,423.622,424.927,426.57,429.367,433.005,436.35,440.34,444.36,448.44,451.845,454.282,457.582,459.225,462.63,466.65,470.055,471.645,474.944,477.742,479.309,482.107,483.749,487.739,489.704,491.347,494.752,496.394,498.607,502.012,506.032,510.112,514.102,520.244,521.812,524.609,528.247,532.327" svgx:width="0.54,0.21,0.54,0.49,0.29,0.49,0.54,0.31,0.21,0.45,0.21,0.22,0.29,0.49,0.37,0.55,0.53,0.54,0.37,0.49,0.22,0.31,0.53,0.22,0.37,0.21,0.82,0.45,0.45,0.37,0.31,0.45,0.31,0.21,0.54,0.17,0.22,0.37,0.49,0.45,0.53,0.54,0.54,0.45,0.29,0.44,0.22,0.45,0.54,0.45,0.21,0.44,0.37,0.21,0.37,0.22,0.53,0.26,0.22,0.45,0.22,0.29,0.45,0.54,0.54,0.53,0.82,0.21,0.37,0.49,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">differential response to simvastatin: secondary analysis of a randomised </text>
   <text y="471.638" x="319.725,323.07,327.06,331.08,333.398,335.528,339.518,341.108,342.698,346.335,350.415,352.058,354.375,356.64,358.208,361.613,363.12,364.425,366.068,369.428,372.833,376.853,380.198,383.835,386.153,387.795,391.62,395.257,398.055,402.195,403.762,405.975,407.617,413.512,417.15,421.23,422.872,426.532,427.837,431.497,435.157,438.817,442.567,446.227,449.887" svgx:width="0.45,0.53,0.54,0.31,0.29,0.53,0.21,0.21,0.49,0.54,0.22,0.31,0.29,0.21,0.45,0.21,0.17,0.22,0.45,0.45,0.54,0.45,0.49,0.31,0.22,0.5,0.49,0.37,0.55,0.21,0.29,0.22,0.78,0.49,0.54,0.22,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">controlled trial. Lancet Respir Med 6:691–698</text>
   <text y="480.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,324.45,328.433,332.453,336.533,338.175,339.758,342.465,343.77,345.098,348.091,352.081,353.724,357.459,361.359,362.664,364.306,367.538,371.176,374.814,376.456,380.731,384.631,385.936,387.578,390.811,394.448,398.086,399.728,403.463,406.823,408.128,409.395,412.748,416.153,420.173,421.553,427.868,433.673,434.978,436.62,440.895,444.915,448.32,452.34,453.983,457.882,459.187,460.829,465.104,469.124,472.529,476.549,477.929,484.079,489.914,491.219,492.862,497.647,501.727,505.132,506.699,508.342,512.721,518.526,519.831,521.473,524.833,528.193,533.608" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.63,0.53,0.54,0.54,0.22,0.21,0.46,0.17,0.22,0.47,0.53,0.22,0.5,0.5,0.17,0.22,0.45,0.49,0.49,0.22,0.57,0.5,0.17,0.22,0.45,0.49,0.49,0.22,0.5,0.45,0.17,0.22,0.5,0.45,0.54,0.22,0.82,0.82,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.82,0.78,0.17,0.22,0.64,0.54,0.45,0.21,0.22,0.57,0.82,0.17,0.22,0.45,0.45,0.72,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 37. Hung IF, To KK, Lee CK, Lee KL, Yan WW, Chan K, Chan WM, Ngai CW, Law </text>
   <text y="489.638" x="319.725,323.46,325.043,326.348,327.99,332.265,336.285,340.238,345.653,347.295,350.76,354.12,355.425,357.068,360.428,361.995,365.978,367.62,371.408,372.713,374.355,377.715,381.12,382.688,384.33,388.065,391.229,392.534,394.177,397.537,400.942,404.924,406.567,410.722,414.997,416.302,417.944,421.304,422.872,426.854,428.497,431.977,436.702,438.007,439.649,443.924,447.944,451.349,455.369,457.012,460.747,465.472,466.777,468.419,471.779,473.347,477.367,479.009,483.284,487.184,488.489,489.757,493.214,497.197,500.834,504.854,506.497,510.232,514.004,515.647,517.634,521.294,524.954,528.614,532.274,534.262" svgx:width="0.5,0.21,0.17,0.22,0.57,0.54,0.53,0.72,0.22,0.46,0.45,0.17,0.22,0.45,0.21,0.53,0.22,0.5,0.17,0.22,0.45,0.45,0.21,0.22,0.5,0.5,0.17,0.22,0.45,0.45,0.53,0.22,0.57,0.57,0.17,0.22,0.45,0.21,0.53,0.22,0.46,0.63,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.63,0.17,0.22,0.45,0.21,0.54,0.22,0.57,0.5,0.17,0.22,0.5,0.53,0.49,0.54,0.22,0.5,0.5,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">KI, Chow FL, Liu R, Lai KY, Lau CC, Liu SH, Chan KH, Lin CK, Yuen KY (2013) </text>
   <text y="498.638" x="319.725,324.555,327.855,331.995,335.633,337.897,339.465,345.607,351.75,355.732,359.752,363.39,365.032,366.615,370.432,372.075,373.642,379.785,385.927,389.91,393.93,397.92,402.0,403.59,407.58,411.72,415.702,417.292,418.86,422.88,424.522,426.84,428.97,432.607,436.012,438.33,444.472,448.11,452.13,454.447,455.752,457.395,460.8,462.442,468.585,472.567,474.157,476.475,478.042,481.387,485.025,489.045,491.317,494.955,497.167,498.81,502.89,506.88,510.862,515.002,516.592,520.424" svgx:width="0.63,0.44,0.55,0.49,0.29,0.21,0.82,0.82,0.53,0.54,0.49,0.22,0.21,0.51,0.22,0.21,0.82,0.82,0.53,0.54,0.53,0.54,0.21,0.53,0.55,0.53,0.21,0.21,0.54,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.17,0.22,0.45,0.22,0.82,0.53,0.21,0.31,0.21,0.45,0.49,0.54,0.31,0.49,0.29,0.22,0.54,0.53,0.53,0.55,0.21,0.49,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Hyperimmune IV immunoglobulin treatment: a multicenter double-</text>
   <text y="507.638" x="319.725,323.865,325.455,327.023,331.043,335.123,336.765,338.978,342.383,346.403,350.483,354.473,360.615,362.183,365.145,368.783,372.863,374.505,377.85,381.84,385.86,388.178,390.308,394.298,395.888,397.478,401.115,405.195,406.838,409.155,411.42,412.988,416.393,417.983,419.625,421.478,425.468,427.68,429.323,433.463,436.868,439.185,440.753,444.39,448.41,450.728,453.525,455.168,460.583,462.15,464.468,468.488,470.13,472.928,476.595,479.933,483.57,485.7,489.338,490.98,494.64,498.3,501.96,505.62,507.263,508.83,512.85,516.48,520.463,524.1,528.12,531.143,534.548" svgx:width="0.55,0.21,0.21,0.54,0.54,0.22,0.29,0.45,0.54,0.54,0.53,0.82,0.21,0.4,0.49,0.54,0.22,0.45,0.53,0.54,0.31,0.29,0.53,0.21,0.21,0.49,0.54,0.22,0.31,0.29,0.21,0.45,0.21,0.22,0.26,0.53,0.29,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.49,0.49,0.49,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">blind randomized controlled trial for patients with severe 2009 influenza </text>
   <text y="516.638" x="319.725,324.113,326.1,330.825,334.485,339.27,342.93,344.918,346.56,348.128,352.148,354.0,357.638,361.065,363.383,364.95,368.94,372.96,374.265,375.908,380.183,384.203,387.84,390.638,392.955,394.598,398.258,401.918,405.578,406.883,410.543,414.203,417.863,421.613,425.273,428.933" svgx:width="0.58,0.26,0.63,0.49,0.64,0.49,0.26,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.17,0.22,0.57,0.54,0.49,0.37,0.31,0.22,0.49,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">A(H1N1) infection. Chest 144:464–473</text>
   <text y="525.638" x="304.725,305.723,309.383,313.043,314.348,315.998,319.725,324.578,327.938,331.275,334.943,338.243,339.885,343.785,346.935,348.24,349.882,352.47,354.345,355.65,356.955,358.597,361.807,365.445,367.71,371.73,375.135,379.155,383.235,386.872,389.895,392.242,396.517,398.73,402.712,405.735,407.377,410.872,412.177,413.819,419.714,423.119,425.391,428.646,432.599,438.014,439.581,441.899,444.921,446.564,451.349,452.654,454.296,457.866,461.504,463.821,466.139,467.781,471.261,472.566,474.209,477.996,481.401,485.541,487.109,490.364,494.001,496.214,497.856,502.176,506.856,508.161,509.541,515.496,519.134,523.154" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.65,0.45,0.45,0.49,0.44,0.22,0.5,0.47,0.17,0.22,0.34,0.29,0.17,0.17,0.22,0.46,0.49,0.29,0.54,0.45,0.54,0.54,0.49,0.4,0.3,0.57,0.29,0.53,0.4,0.22,0.47,0.17,0.22,0.78,0.45,0.29,0.42,0.53,0.72,0.21,0.31,0.4,0.22,0.64,0.17,0.22,0.5,0.49,0.31,0.31,0.22,0.46,0.17,0.22,0.5,0.45,0.55,0.21,0.42,0.49,0.29,0.22,0.58,0.62,0.17,0.22,0.82,0.49,0.54,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 38. Davey RT, Jr., Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wen-</text>
   <text y="534.638" x="319.725,322.125,327.488,331.478,333.885,336.202,340.222,341.865,346.492,347.797,349.44,353.295,357.315,361.297,363.51,366.915,370.935,374.34,375.982,379.462,380.767,382.41,385.905,389.925,394.005,397.642,401.662,403.305,408.09,409.395,411.037,415.754,419.744,421.874,425.954,427.522,431.542,433.184,435.892,437.197,438.839,441.427,444.832,446.399,450.419,452.062,457.897,461.796,463.101,464.744,468.666,472.071,476.091,477.471,480.944,482.249,483.891,487.461,491.451,493.041,494.609,497.631,500.594,504.583,506.901,509.173,513.164,514.806,520.641,525.426,526.731" svgx:width="0.31,0.72,0.53,0.29,0.31,0.54,0.22,0.65,0.17,0.22,0.5,0.54,0.53,0.29,0.45,0.54,0.45,0.22,0.46,0.17,0.22,0.47,0.54,0.54,0.49,0.54,0.22,0.64,0.17,0.22,0.62,0.53,0.29,0.54,0.21,0.54,0.22,0.46,0.17,0.22,0.34,0.45,0.21,0.54,0.22,0.78,0.5,0.17,0.22,0.5,0.45,0.54,0.22,0.51,0.17,0.22,0.5,0.53,0.21,0.21,0.4,0.4,0.53,0.31,0.31,0.53,0.22,0.78,0.64,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">tworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, </text>
   <text y="543.638" x="319.725,323.595,325.163,327.96,331.327,334.732,336.375,339.105,340.41,342.052,345.84,349.822,353.04,355.252,359.235,363.255,367.335,369.652,373.672,377.077,383.22,384.862,388.762,390.067,391.395,394.387,398.025,404.167,407.805,410.602,414.682,418.32,422.34,423.982,428.025,429.329,430.972,434.204,438.187,442.207,446.287,450.307,452.437,456.074,460.094,461.737,464.212,465.517,467.159,470.947,474.584,476.152,480.232,483.869,485.459,487.102,489.689,494.414,495.719,497.362,500.722,504.127,508.147,511.784,513.427,518.152,522.427,523.732" svgx:width="0.5,0.21,0.37,0.42,0.45,0.22,0.5,0.17,0.22,0.5,0.53,0.43,0.29,0.53,0.54,0.54,0.31,0.54,0.45,0.82,0.22,0.5,0.17,0.22,0.47,0.49,0.82,0.49,0.37,0.54,0.49,0.54,0.22,0.54,0.17,0.22,0.45,0.53,0.54,0.54,0.54,0.29,0.49,0.54,0.22,0.34,0.17,0.22,0.5,0.49,0.21,0.54,0.49,0.21,0.22,0.34,0.63,0.17,0.22,0.45,0.45,0.54,0.49,0.22,0.63,0.57,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, </text>
   <text y="552.638" x="319.725,324.51,328.148,331.553,333.825,337.815,341.835,343.478,346.065,350.693,351.998,353.64,358.493,361.853,365.19,368.858,372.158,373.8,377.7,380.85,382.155,383.797,387.007,390.645,392.91,396.93,400.335,404.355,408.435,412.072,415.095,417.441,421.716,423.929,427.911,430.934,432.576,436.071,437.376,439.019,444.914,448.319,450.591,453.845,457.798,463.213,464.78,467.098,470.12,471.763,476.548,477.853,479.495,483.065,486.703,489.02,491.338,492.98,496.46,497.765,499.408,503.195,506.6,510.74,512.308,515.563,519.2,521.413,523.055,527.375,532.055,533.36" svgx:width="0.64,0.49,0.45,0.31,0.53,0.54,0.22,0.34,0.65,0.17,0.22,0.65,0.45,0.45,0.49,0.44,0.22,0.5,0.47,0.17,0.22,0.46,0.49,0.29,0.54,0.45,0.54,0.54,0.49,0.4,0.3,0.57,0.29,0.53,0.4,0.22,0.47,0.17,0.22,0.78,0.45,0.29,0.42,0.53,0.72,0.21,0.31,0.4,0.22,0.64,0.17,0.22,0.5,0.49,0.31,0.31,0.22,0.46,0.17,0.22,0.5,0.45,0.55,0.21,0.42,0.49,0.29,0.22,0.58,0.62,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Neaton JD, Davey RT, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, </text>
   <text y="561.638" x="319.725,325.68,329.318,333.338,335.738,341.1,345.09,347.497,349.815,353.835,355.477,360.105,361.41,363.052,366.907,370.927,374.91,377.122,380.527,384.547,387.952,389.595,393.075,394.38,396.022,399.517,403.537,407.617,411.255,415.275,416.917,421.702,423.007,424.649,429.367,433.357,435.487,439.567,441.134,445.154,446.797,449.504,450.809,452.452,455.039,458.444,460.012,464.032,465.674,471.509,475.409,476.714,478.357,482.279,485.684,489.704,491.084,494.557,495.862,497.504,501.074,505.064,506.654,508.222,511.244,514.207,518.197,520.514,522.786,526.776" svgx:width="0.82,0.49,0.54,0.31,0.72,0.53,0.29,0.31,0.54,0.22,0.65,0.17,0.22,0.5,0.54,0.53,0.29,0.45,0.54,0.45,0.22,0.46,0.17,0.22,0.47,0.54,0.54,0.49,0.54,0.22,0.64,0.17,0.22,0.62,0.53,0.29,0.54,0.21,0.54,0.22,0.46,0.17,0.22,0.34,0.45,0.21,0.54,0.22,0.78,0.5,0.17,0.22,0.5,0.45,0.54,0.22,0.51,0.17,0.22,0.5,0.53,0.21,0.21,0.4,0.4,0.53,0.31,0.31,0.53,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto </text>
   <text y="570.638" x="319.725,325.56,330.345,331.65,333.293,337.162,338.73,341.527,344.895,348.3,349.942,352.672,353.977,355.62,359.407,363.39,366.607,368.82,372.802,376.822,380.902,383.22,387.24,390.645,396.787,398.43,402.33,403.635,404.962,407.955,411.592,417.735,421.372,424.17,428.25,431.887,435.907,437.549,441.592,442.897,444.539,447.772,451.754,455.774,459.854,463.874,466.004,469.642,473.662,475.304,477.779,479.084,480.727,484.514,488.152,489.719,493.799,497.437,499.027,500.669,503.257,507.982,509.287,510.929,514.289,517.694,521.714,525.352,526.995,531.719,535.995,537.299" svgx:width="0.78,0.64,0.17,0.22,0.5,0.21,0.37,0.42,0.45,0.22,0.5,0.17,0.22,0.5,0.53,0.43,0.29,0.53,0.54,0.54,0.31,0.54,0.45,0.82,0.22,0.5,0.17,0.22,0.47,0.49,0.82,0.49,0.37,0.54,0.49,0.54,0.22,0.54,0.17,0.22,0.45,0.53,0.54,0.54,0.54,0.29,0.49,0.54,0.22,0.34,0.17,0.22,0.5,0.49,0.21,0.54,0.49,0.21,0.22,0.34,0.63,0.17,0.22,0.45,0.45,0.54,0.49,0.22,0.63,0.57,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, </text>
   <text y="579.638" x="319.725,324.51,328.148,331.553,333.825,337.815,341.835,343.478,346.065,350.693,351.998,353.64,357.428,361.41,363.728,366.045,368.843,370.485,372.96,374.265,375.907,380.805,384.442,388.462,392.482,394.05,398.07,402.15,403.792,407.287,408.592,410.235,415.087,419.07,423.345,427.365,431.002,435.022,438.66,440.302,444.69,445.995,447.637,451.484,453.697,457.68,463.822,465.464,468.959,470.264,471.907,476.632,480.037,482.302,484.567,486.134,488.932,492.922,496.942,498.584,504.419,505.724,507.367,513.262,516.899,520.979,524.617,526.829" svgx:width="0.64,0.49,0.45,0.31,0.53,0.54,0.22,0.34,0.65,0.17,0.22,0.5,0.53,0.31,0.31,0.37,0.22,0.34,0.17,0.22,0.65,0.49,0.54,0.54,0.21,0.54,0.54,0.22,0.47,0.17,0.22,0.65,0.53,0.57,0.54,0.49,0.54,0.49,0.22,0.58,0.17,0.22,0.5,0.29,0.53,0.82,0.22,0.47,0.17,0.22,0.63,0.45,0.29,0.29,0.21,0.37,0.53,0.54,0.22,0.78,0.17,0.22,0.78,0.49,0.54,0.49,0.29,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Neaton JD, Butts J, Denning E, DuChene A, Krum E, Harrison M, Meger </text>
   <text y="588.638" x="319.725,323.205,324.51,326.153,329.723,333.36,335.633,339.27,341.483,344.28,348.27,352.29,353.933,357.72,359.025,360.668,365.7,369.683,373.088,377.108,378.75,382.65,383.955,385.597,389.077,393.097,396.502,400.485,404.565,408.585,412.605,416.242,419.04,421.837,425.137,426.779,432.614,433.919,435.247,438.704,442.724,446.714,452.857,456.997,459.794,463.784,467.804,469.447,474.127,475.432,476.812,480.434,484.424,487.769,490.942,492.584,497.212,498.517,500.159,506.054,509.692,511.964,515.309,518.714,520.304,522.269" svgx:width="0.46,0.17,0.22,0.5,0.49,0.31,0.49,0.29,0.37,0.53,0.54,0.22,0.5,0.17,0.22,0.67,0.53,0.45,0.54,0.22,0.5,0.17,0.22,0.46,0.54,0.45,0.53,0.54,0.54,0.54,0.49,0.37,0.37,0.44,0.22,0.78,0.17,0.22,0.47,0.54,0.53,0.82,0.55,0.37,0.53,0.54,0.22,0.62,0.17,0.22,0.51,0.53,0.45,0.42,0.22,0.65,0.17,0.22,0.78,0.49,0.31,0.45,0.45,0.21,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">S, Peterson R, Quan K, Shaughnessy M, Thompson G, Vock D, Metcalf </text>
   <text y="597.638" x="319.725,322.2,323.505,325.148,330.045,333.712,339.127,342.532,344.745,346.387,350.175,351.48,353.122,356.947,360.585,364.605,370.747,374.152,378.172,379.5,382.65,383.955,385.597,390.382,393.787,396.105,399.51,401.722,405.127,406.732,410.137,414.157,415.537,419.01,420.315,421.957,427.852,431.197,435.427,439.417,443.437,447.457,451.094,452.684,454.274,455.917,459.704,461.009,462.652,465.982,467.572,471.524,476.887,480.524,482.737,485.534,487.177,490.672,491.977,493.619,497.099,503.242,504.809,507.127,511.147,512.789,516.689,517.994" svgx:width="0.34,0.17,0.22,0.65,0.49,0.72,0.45,0.29,0.22,0.5,0.17,0.22,0.5,0.49,0.54,0.82,0.45,0.54,0.22,0.47,0.17,0.22,0.64,0.45,0.31,0.45,0.29,0.45,0.21,0.45,0.54,0.22,0.51,0.17,0.22,0.78,0.45,0.57,0.53,0.54,0.54,0.49,0.21,0.21,0.22,0.5,0.17,0.22,0.46,0.21,0.53,0.72,0.49,0.29,0.37,0.22,0.47,0.17,0.22,0.46,0.82,0.21,0.31,0.54,0.22,0.5,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">J, Dewar R, Rehman T, Natarajan V, McConnell R, Flowers E, Smith K, </text>
   <text y="606.638" x="319.725,324.45,328.44,332.393,335.73,339.368,341.58,343.223,349.058,350.363,352.005,356.235,360.188,363.488,365.078,368.715,370.358,373.853,379.688,380.993,382.635,388.5,392.483,396.503,398.633,402.623,406.26,407.903,412.53,413.835,415.477,419.91,423.315,427.395,430.8,434.205,436.335,440.415,442.057,445.762,447.067,448.71,452.28,455.917,459.322,461.535,464.332,468.322,472.342,473.984,479.819,481.124,482.767,486.989,490.972,493.184,495.982,497.572,501.239,504.539,506.182,510.569,511.874,513.255,519.21,522.848,526.988,531.128" svgx:width="0.63,0.53,0.53,0.45,0.49,0.29,0.22,0.78,0.17,0.22,0.57,0.53,0.44,0.21,0.49,0.22,0.47,0.78,0.17,0.22,0.78,0.53,0.54,0.29,0.53,0.49,0.22,0.65,0.17,0.22,0.58,0.45,0.54,0.45,0.45,0.29,0.54,0.22,0.5,0.17,0.22,0.5,0.49,0.45,0.29,0.37,0.53,0.54,0.22,0.78,0.17,0.22,0.57,0.53,0.29,0.37,0.21,0.49,0.44,0.22,0.58,0.17,0.22,0.82,0.49,0.55,0.55,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Hoover M, Coyle EM, Munroe D, Aagaard B, Pearson M, Cursley A, Webb </text>
   <text y="615.638" x="319.725,324.45,325.755,327.398,332.123,336.105,340.185,342.983,346.973,350.993,352.635,355.343,356.648,358.29,362.078,366.06,368.858,371.655,375.293,376.883,378.473,380.115,384.39,385.695,387.338,390.818,394.118,395.76,400.148,401.453,403.095,406.726,410.709,413.146,416.536,418.104,420.901,422.544,426.819,428.124,429.766,432.353,435.758,439.103,442.276,445.073,449.063,453.083,454.726,458.431,459.736,461.378,465.608,469.598,471.188,472.778,476.183,479.528,483.623,485.858,491.754,495.744,497.957,501.362,504.999,507.797,509.064,512.229,513.534,515.177,519.422,522.827,524.957,528.624,531.924" svgx:width="0.63,0.17,0.22,0.63,0.53,0.54,0.37,0.53,0.54,0.22,0.46,0.17,0.22,0.5,0.53,0.37,0.37,0.49,0.21,0.21,0.22,0.57,0.17,0.22,0.46,0.44,0.22,0.58,0.17,0.22,0.5,0.53,0.29,0.45,0.21,0.37,0.22,0.57,0.17,0.22,0.34,0.45,0.45,0.42,0.37,0.53,0.54,0.22,0.5,0.17,0.22,0.57,0.53,0.21,0.21,0.45,0.45,0.53,0.3,0.78,0.53,0.29,0.45,0.49,0.37,0.22,0.5,0.17,0.22,0.57,0.45,0.29,0.49,0.44,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">H, Hudson F, Russell C, Sy A, Purvis C, Jackson B, Collaco-Moraes Y, Carey </text>
   <text y="624.638" x="319.725,324.353,325.658,327.3,331.125,335.115,339.255,342.053,346.043,350.063,351.705,355.493,356.798,358.44,361.92,365.325,369.345,372.69,376.71,380.348,383.37,385.013,389.4,390.705,392.348,395.588,397.155,401.175,402.765,406.433,409.733,411.375,414.87,416.175,417.818,422.048,426.038,429.983,435.345,438.983,440.573,442.163,443.805,448.433,449.738,451.38,454.612,458.602,461.399,464.197,468.187,469.829,475.664,480.389,481.694,483.337,488.077,491.482,497.624,501.764,505.169,507.299,511.379,515.017,516.607,518.197,521.602,523.244,526.604,527.909" svgx:width="0.65,0.17,0.22,0.5,0.53,0.55,0.37,0.53,0.54,0.22,0.5,0.17,0.22,0.46,0.45,0.54,0.45,0.54,0.49,0.4,0.22,0.58,0.17,0.22,0.46,0.21,0.54,0.21,0.49,0.44,0.22,0.47,0.17,0.22,0.57,0.53,0.54,0.72,0.49,0.21,0.21,0.22,0.65,0.17,0.22,0.45,0.53,0.37,0.37,0.53,0.22,0.78,0.63,0.17,0.22,0.62,0.45,0.82,0.55,0.45,0.29,0.54,0.49,0.21,0.21,0.45,0.22,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">D, Robson R, Sánchez A, Finley E, Conwell D, Losso MH, Gambardella L, </text>
   <text y="633.638" x="319.725,324.113,328.253,331.89,333.48,336.885,338.528,342.803,344.108,345.75,348.983,352.973,357.113,360.75,363.773,365.415,368.145,369.45,371.093,375.48,377.07,381.06,385.08,387.878,391.868,393.51,398.235,399.54,400.868,403.86,407.85,411.833,413.423,417.413,421.395,427.538,429.105,430.748,435.428,436.733,438.375,443.055,444.623,448.613,452.595,455.963,459.368,461.633,463.2,464.58,468.053,469.358,471.0,475.388,479.408,482.813,486.833,490.853,494.843,497.64,499.913,503.903,507.885,509.528,514.335,515.64,517.283,521.558,524.948,526.515,530.535" svgx:width="0.58,0.55,0.49,0.21,0.45,0.22,0.57,0.17,0.22,0.45,0.53,0.55,0.49,0.4,0.22,0.5,0.17,0.22,0.58,0.21,0.53,0.54,0.37,0.53,0.22,0.63,0.17,0.22,0.47,0.53,0.53,0.21,0.53,0.53,0.82,0.21,0.22,0.62,0.17,0.22,0.62,0.21,0.53,0.53,0.42,0.45,0.29,0.21,0.22,0.51,0.17,0.22,0.58,0.54,0.45,0.54,0.54,0.53,0.37,0.31,0.53,0.53,0.22,0.67,0.17,0.22,0.58,0.45,0.21,0.54,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Abela C, Lopez P, Alonso H, Touloumi G, Gioukari V, Anagnostou O, Avih-</text>
   <text y="642.638" x="319.725,321.293,325.313,329.393,332.19,335.595,339.615,343.605,347.625,349.268,353.655,354.96,356.603,360.233,364.215,367.013,369.81,373.215,377.295,380.933,384.57,386.213,390.112,391.417,393.06,397.755,401.895,405.885,407.475,410.775,414.18,420.322,421.964,425.444,426.749,428.392,433.424,439.567,443.557,445.829,449.819,452.617,456.637,460.627,462.269,465.974,467.279,468.922,472.439,476.429,478.019,482.009,484.297,487.319,490.724,494.744,498.734,500.377,504.652,505.957,507.599,511.169,514.807,517.079,520.717,522.929,525.727,529.364,533.384" svgx:width="0.21,0.54,0.54,0.37,0.45,0.54,0.53,0.54,0.22,0.58,0.17,0.22,0.5,0.53,0.37,0.37,0.45,0.54,0.49,0.49,0.22,0.5,0.17,0.22,0.63,0.55,0.53,0.21,0.44,0.45,0.82,0.22,0.46,0.17,0.22,0.67,0.82,0.53,0.31,0.53,0.37,0.54,0.53,0.22,0.5,0.17,0.22,0.46,0.53,0.21,0.53,0.29,0.4,0.45,0.54,0.53,0.22,0.57,0.17,0.22,0.5,0.49,0.31,0.49,0.29,0.37,0.49,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ingsanon A, Pussadee K, Ubolyam S, Omotosho B, Solórzano C, Petersen </text>
   <text y="651.638" x="319.725,322.875,324.18,325.56,329.378,332.678,335.475,338.775,342.18,344.393,347.798,349.403,353.385,355.028,358.928,360.233,361.875,365.745,367.312,370.335,373.357,376.762,378.405,381.885,386.272,387.577,388.957,395.107,399.127,400.695,403.012,406.417,409.671,413.309,415.521,417.164,419.751,424.139,425.444,427.086,431.871,435.276,439.296,441.509,444.914,446.556,450.344,451.649,453.291,457.079,460.484,463.799,466.071,469.709,471.921,473.564,476.039,477.344,478.986,483.216,487.206,491.346,495.329,497.594,501.614,503.256,505.986,507.291,508.934,513.673,517.078,519.209,523.289,527.309,530.946,533.159" svgx:width="0.47,0.17,0.22,0.51,0.44,0.37,0.44,0.45,0.29,0.45,0.21,0.53,0.22,0.5,0.17,0.22,0.5,0.21,0.4,0.4,0.45,0.22,0.46,0.58,0.17,0.22,0.82,0.54,0.21,0.31,0.45,0.42,0.49,0.29,0.22,0.34,0.58,0.17,0.22,0.64,0.45,0.54,0.29,0.45,0.22,0.5,0.17,0.22,0.5,0.45,0.43,0.31,0.49,0.29,0.22,0.34,0.17,0.22,0.57,0.53,0.55,0.53,0.29,0.54,0.22,0.5,0.17,0.22,0.62,0.45,0.29,0.54,0.54,0.49,0.29,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">T, Vysyaraju K, Rizza SA, Whitaker JA, Nahra R, Baxter J, Coburn P, Gardner </text>
   <text y="660.638" x="319.725,323.22,329.055,330.36,332.003,335.52,338.865,342.855,345.173,347.49,349.133,351.72,356.108,357.413,359.055,362.153,365.558,369.698,373.335,375.548,377.19,380.55,381.855,383.498,387.038,390.443,393.24,395.513,399.503,401.715,403.358,406.853,408.158,409.8,415.695,419.1,422.354,426.344,430.364,434.354,438.374,440.017,443.377,444.682,446.324,452.219,455.624,458.969,463.357,465.764,468.082,472.102,476.084,478.297,479.939,483.727,488.114,489.419,491.062,495.899,497.467,499.057,500.647,506.789,510.194,514.214,515.857,519.217,525.052,526.357" svgx:width="0.47,0.78,0.17,0.22,0.46,0.45,0.53,0.31,0.31,0.22,0.34,0.58,0.17,0.22,0.46,0.45,0.55,0.49,0.29,0.22,0.45,0.17,0.22,0.5,0.45,0.37,0.31,0.53,0.29,0.22,0.47,0.17,0.22,0.78,0.45,0.42,0.53,0.54,0.53,0.54,0.22,0.45,0.17,0.22,0.78,0.45,0.45,0.58,0.29,0.31,0.54,0.53,0.29,0.22,0.5,0.58,0.17,0.22,0.63,0.21,0.21,0.21,0.82,0.45,0.54,0.22,0.45,0.78,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">EM, Scott JA, Faber L, Pastor E, Makohon L, MacArthur RA, Hillman LM, </text>
   <text y="669.638" x="319.725,322.823,326.228,328.493,330.623,334.613,338.595,342.675,346.695,348.338,354.173,356.647,357.952,359.595,363.165,367.155,368.745,372.382,376.402,379.807,383.062,387.015,390.405,391.972,395.145,396.787,401.512,407.347,408.652,410.294,414.569,416.159,419.564,421.837,425.009,426.652,430.012,434.399,435.704,437.347,441.576,445.566,447.156,451.146,455.166,456.809,460.596,463.071,464.376,466.019,469.754,473.736,477.756,479.324,482.121,485.526,488.864,490.431,492.074,495.809,501.644,502.949,504.591,509.489,513.126,517.355,521.345,525.365,528.71,530.278,534.298,535.865" svgx:width="0.46,0.45,0.29,0.29,0.53,0.53,0.54,0.54,0.22,0.78,0.34,0.17,0.22,0.5,0.53,0.21,0.49,0.54,0.45,0.42,0.53,0.45,0.21,0.42,0.22,0.63,0.78,0.17,0.22,0.57,0.21,0.45,0.29,0.42,0.22,0.45,0.58,0.17,0.22,0.57,0.53,0.21,0.53,0.54,0.22,0.5,0.34,0.17,0.22,0.5,0.53,0.54,0.21,0.37,0.45,0.42,0.21,0.22,0.5,0.78,0.17,0.22,0.65,0.49,0.57,0.53,0.54,0.45,0.21,0.54,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Farrough MJ, Polenakovik HM, Clark LA, Colon RJ, Kunisaki KM, DeConcini </text>
   <text y="678.638" x="319.725,325.56,326.865,328.508,331.125,335.115,339.135,343.155,345.953,349.943,353.963,355.605,359.085,363.473,364.778,366.158,372.113,376.103,377.693,379.545,383.183,384.825,389.1,392.888,394.193,395.835,401.67,404.895,408.878,415.02,419.16,422.565,424.208,427.568,428.873,430.515,434.76,438.165,440.438,444.578,448.568,452.588,456.608,460.245,463.65,467.633,469.275,471.863,475.028,476.333,477.975,483.87,487.86,490.125,492.39,493.958,496.755,498.398,502.785,504.09,505.733,508.973,510.54,512.857,515.88,520.02,523.425,525.743,528.008,529.575,532.92,536.093" svgx:width="0.78,0.17,0.22,0.34,0.53,0.54,0.54,0.37,0.53,0.54,0.22,0.46,0.58,0.17,0.22,0.82,0.53,0.21,0.26,0.49,0.22,0.57,0.5,0.17,0.22,0.78,0.42,0.53,0.82,0.55,0.45,0.22,0.45,0.17,0.22,0.57,0.45,0.29,0.55,0.53,0.54,0.54,0.49,0.45,0.53,0.22,0.34,0.5,0.17,0.22,0.78,0.53,0.29,0.29,0.21,0.37,0.22,0.58,0.17,0.22,0.46,0.21,0.31,0.4,0.55,0.45,0.31,0.29,0.21,0.45,0.42,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">M, Johnson SA, Wolfe CR, Mkumba L, Carbonneau JY, Morris A, Fitzpatrick </text>
   <text y="687.638" x="319.725,325.56,329.055,330.36,332.003,335.82,339.458,342.255,345.053,346.62,350.64,354.72,358.358,360.57,362.213,366.488,368.962,370.267,371.91,375.39,378.795,380.385,383.79,386.107,389.512,391.155,394.942,399.33,400.635,402.277,406.665,409.071,411.344,414.981,417.194,419.991,421.634,425.435,429.823,431.128,432.455,435.478,438.883,441.68,443.248,444.89,449.165,455.0,456.305,457.948,461.488,464.893,468.913,472.903,475.7,477.343,481.13,483.605,484.91,486.553,489.913,493.318,496.663,500.683,502.325,505.685,510.073,511.378,513.02,517.7,519.29,522.928,525.725,529.827,533.127" svgx:width="0.78,0.47,0.17,0.22,0.5,0.49,0.37,0.37,0.21,0.54,0.54,0.49,0.29,0.22,0.57,0.34,0.17,0.22,0.46,0.45,0.21,0.45,0.31,0.45,0.22,0.5,0.58,0.17,0.22,0.58,0.29,0.31,0.49,0.29,0.37,0.22,0.5,0.58,0.17,0.22,0.47,0.45,0.37,0.21,0.22,0.57,0.78,0.17,0.22,0.5,0.45,0.54,0.53,0.37,0.22,0.5,0.34,0.17,0.22,0.45,0.45,0.45,0.54,0.22,0.45,0.58,0.17,0.22,0.62,0.21,0.49,0.37,0.55,0.44,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ME, Kessinger CJ, Salata RA, Arters KA, Tasi CM, Panos RJ, Lach LA, Glesby </text>
   <text y="696.638" x="319.725,325.56,328.035,329.34,330.983,335.708,339.113,345.255,346.898,350.7,355.088,356.393,358.035,362.76,366.743,370.823,374.843,378.48,381.278,382.658,386.513,391.193,392.498,394.14,397.658,401.003,405.023,409.013,413.003,414.593,418.26,421.56,423.203,427.103,430.253,431.558,433.2,437.475,439.605,443.595,447.578,450.923,454.943,456.585,461.212,462.517,464.159,470.024,474.007,476.324,478.597,482.234,484.447,487.852,489.494,492.854,494.159,495.802,500.587,504.539,507.929,511.334,514.507,516.149,519.937,525.772,527.077" svgx:width="0.78,0.34,0.17,0.22,0.63,0.45,0.82,0.22,0.5,0.58,0.17,0.22,0.63,0.53,0.54,0.54,0.49,0.37,0.22,0.51,0.62,0.17,0.22,0.46,0.45,0.54,0.53,0.53,0.21,0.49,0.44,0.22,0.5,0.47,0.17,0.22,0.57,0.29,0.53,0.53,0.45,0.54,0.22,0.65,0.17,0.22,0.78,0.53,0.31,0.31,0.49,0.29,0.45,0.22,0.45,0.17,0.22,0.64,0.53,0.45,0.45,0.42,0.22,0.5,0.78,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">MJ, Ham KA, Hughes VG, Schooley RT, Crouch D, Muttera L, Novak RM, </text>
   <text y="705.638" x="319.725,323.513,325.103,328.74,332.145,334.943,339.023,342.428,344.018,347.655,349.298,352.778,357.053,358.358,360.0,364.005,367.988,371.333,374.587,378.225,380.49,386.632,390.037,394.057,395.7,400.087,403.582,404.887,406.53,412.425,415.83,419.85,423.84,426.637,430.62,432.937,436.957,438.525,439.905,445.71,447.014,448.342,451.799,455.819,459.224,463.214,467.159,470.407,474.044,478.064,479.707,483.187,484.492,486.134,490.409,494.429,495.997,499.664,505.027,508.372,512.392,515.797,518.062,522.082,523.409,526.559,527.864" svgx:width="0.5,0.21,0.49,0.45,0.37,0.54,0.45,0.21,0.49,0.22,0.46,0.57,0.17,0.22,0.54,0.53,0.45,0.42,0.49,0.29,0.82,0.45,0.54,0.22,0.58,0.47,0.17,0.22,0.78,0.45,0.54,0.53,0.37,0.53,0.31,0.54,0.21,0.22,0.82,0.17,0.22,0.47,0.54,0.45,0.53,0.54,0.44,0.49,0.54,0.22,0.46,0.17,0.22,0.57,0.54,0.21,0.49,0.72,0.45,0.54,0.45,0.29,0.54,0.22,0.47,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Bleasdale SC, Zuckerman AE, Manosuthi W, Thaonyen S, Chiewcharn T, </text>
   <text y="714.638" x="319.725,323.205,327.188,332.603,336.008,340.028,344.168,345.735,351.878,355.868,357.458,360.683,364.665,366.255,367.898,372.578,373.883,375.525,380.265,383.67,385.943,389.58,392.925,396.945,400.928,407.07,411.21,415.2,416.79,418.433,421.913,423.218,424.86,428.648,432.63,436.65,440.79,444.195,446.993,450.398,454.418,458.498,460.14,463.62,464.925,466.568,470.955,474.975,479.055,483.038,485.835,487.478,491.265,493.74,495.045,496.688,501.075,505.095,509.175,512.813,515.025,517.823,521.813,525.833,527.475,533.31,534.615" svgx:width="0.46,0.53,0.72,0.45,0.54,0.55,0.21,0.82,0.53,0.21,0.42,0.53,0.21,0.22,0.62,0.17,0.22,0.62,0.45,0.31,0.49,0.45,0.54,0.53,0.82,0.55,0.53,0.21,0.22,0.46,0.17,0.22,0.5,0.53,0.54,0.55,0.45,0.37,0.45,0.54,0.54,0.22,0.46,0.17,0.22,0.58,0.54,0.54,0.53,0.37,0.22,0.5,0.34,0.17,0.22,0.58,0.54,0.54,0.49,0.29,0.37,0.53,0.54,0.22,0.78,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Suwanpimolkul G, Gatechumpol S, Bunpasang S, Angus BJ, Anderson M, </text>
   <text y="723.638" x="319.725,325.62,329.61,331.755,335.835,339.24,343.26,344.903,350.738,352.043,353.685,359.64,361.208,365.228,367.5,371.49,375.51,377.153,379.628,380.933,382.575,387.255,390.623,394.028,400.17,403.575,405.165,408.803,411.12,413.918,417.908,421.89,423.533,429.368,434.153,435.458,437.1,441.825,445.23,451.373,455.513,457.103,460.74,463.013,467.003,471.023,472.665,475.139,476.444,478.087,481.694,483.959,485.527,488.872,492.509,494.152,498.907,503.294,504.599,506.242,509.602,511.192,514.859,520.222,523.859,525.449,528.749,532.769" svgx:width="0.78,0.53,0.29,0.54,0.45,0.54,0.22,0.78,0.17,0.22,0.78,0.21,0.54,0.31,0.53,0.54,0.22,0.34,0.17,0.22,0.62,0.42,0.45,0.82,0.45,0.21,0.49,0.31,0.37,0.53,0.53,0.22,0.78,0.64,0.17,0.22,0.63,0.45,0.82,0.55,0.21,0.49,0.31,0.53,0.54,0.22,0.34,0.17,0.22,0.5,0.29,0.21,0.45,0.49,0.22,0.65,0.58,0.17,0.22,0.45,0.21,0.49,0.72,0.49,0.21,0.44,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Morgan M, Minton J, Gkamaletsou MN, Hambleton J, Price DA, Llewelyn </text>
  </g>
 </g>
</svg>
